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ABBREVIATIONS 
 
PNP  POO NAGA PARPAM 
No.   Number 
Mg  Milligram 
Kg   Kilogram 
LD50  Lethal Dose50 
ED50  Effective Dose50 
p.o  peros 
ML  Milliliter 
%   percentage 
R&D   Research and Development 
EDTA  Ethylene Diamine Tetra Acetic Acid 
M   Male 
g%   Gram percentage 
g  Gram 
NOAEL  No-Observed-Adverse-Effect-Level 
MLD   Minimum Lethal Dose 
MTD   Maximum Tolerated Dose 
OECD Organization of Economic Co-operation and Development 
CPCSEA  Committee for the Purpose of Control and Supervision of 
Experiments on Animals 
FTIR  Fourier Transform – Infra Red Spectroscopy 
SEM  Scanning Electron Microscopy 
ICP-OES Inductively Coupled Plasma Optical Emission-Spectrometry 
LD Low Dose 
MD Middle Dose 
HD High Dose 
BDL  Below Detection Limit 
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1. INTRODUCTION 
  Siddha system of medicine is one of the ancient system of medicine practiced 
in India.."Siddha" derives from the word of "Siddhar" (Rishi) who formulated this 
therapy. Eighten Siddhars were said to have contributed towards the development of 
this medical system and Father of Siddha System is "LORD AGASTHIYAR" 
(MahaRishi).   
           According to siddhars concept the universe and livelihoods are made up of 
pancha poothas.   
n{<mk<kqZt<tOk!hq{<ml<< < < < << < < < << < < < <!
hq{<mk<kqZt<tOk!n{<ml<< < < < << < < < << < < < <!
n{<mLl<!< << << < hq{<mLl<!ye<Ox< < << < << < < !
nxqf<Kkie<!hii<g<Gl<!OhiOk< < < < << < < < << < < < < !
!!!!!!!!!!!!!!!!!!!!!!!!.!sm<jmLeq!Riel<< << << <!
 In sattai muni gnanam human body is considered as microcosm and the 
universe as macrocosm, both microcosm and macrocosm were made up of 
panchapoothas. Siddha System is based on balancing of equilibrium of five Bhoothas 
(Doshas) as " LAND (Prithvi), WATER (Appu), FIRE( Theyu), AIR (Vayu), SPACE 
(Agayam).      
  Pancha poothas made the human body and vital forces namely vatham, 
pittham and kabam, they were also called as uyir thathukkal.     
!!! lqgqEl<!GjxbqEl<!Ofib<osb<Bl<!F~Ozii<< < < < < << < < < < << < < < < <!
!!!!!utqLkzi!w{<{qb!&e<X< << << < !
- jpUts;Sth;; ;; ;; ; 
  In healthy human the three vital forces were in a balanced state , any 
imbalance in such forces may lead to diseases. 
  Any alteration in food habits, environmental and climatic changes will causes 
diseases. 
     khWghby;yhj cz;bkWj;J cz;zpd;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
    CW ghby;iy caph;f;F; ; ;; ; ;; ; ;  
- jpUts;Sth;; ;; ;; ; 
  Siddha system of medicine strictly advices food habits and its regulations as a 
rule along with the environmental and climatic changes.    
          czNt kUe;J kUe;Nj czT.; ;; ;; ;  
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  So, that the living beings will be free from disease, infections and help them to 
live longer healthy life. Siddhars who identified the nature's herbal medicinal value 
formulated the medicine on the basis of the suvai , gunam,,veeriyam, vibhavam, 
prabhavam of plants. Combined group of herbals to form a drug administrate in the 
infected. 
            Siddha system that insists that the physician should enquire the nature of the 
disease, its  cause and its method of cure and treat it faithfully Envagai Thaervugal 
(the eight methods of clinical examination)  are used to determine the diagnosis, 
aetiology, treatment and prognosis of diseases.   
  Siddhars are men with supernatural power and Medical wisdom. All their 
doing were highly intertwined with nature. They have combined their Medical works 
with astrology, alchemy & philosophy. They were robust in the concept “Nature that 
causes diseases and it is again nature effects their cure” and it is therefore necessary 
that the physician should know the principles of nature. Siddhars were proficient with 
formulations that treat and prevent ailments. The formulations were either purely 
herbal, animal, metals, a combination of herbomineral or metals. Thus for preparing 
medicine, Siddhars solely depend on natural wealth. Siddhars were persons of highly 
cultured intellectual & spiritual faculties with a very vast boundless knowledge about 
medicine and alchemy. 
  Drug means any substance that when taken into a living organism may modify 
physiological system or pathological states.  
  A drug possessing high therapeutic index is said to be safe. Reaction to a drug 
in a subject may vary in accordance with various factors which includes anaphylaxsis, 
idiosyncrasy or accidental overdosing. Variation of dose, duration alters the medicine 
and makes it a poison. 
  Dose and duration of administration of drug is much more important for 
clinical practice. It is the duty of a physician to ensure that the patient is receiving the 
correct dose and is harmless. Or else, the physician will be charged for his medical 
negligence under legal aspects.  
  Toxicology is the science of poison, an evolving discipline, moving from art to 
science from using chemicals which hurt to chemicals that prevent hurting, from 
taking lives to saving lives. It is the aspect of Pharmacology that deals with adverse 
effects of drugs. It is concerned not only with drug used in therapy but also with the 
many other chemicals that may be responsible for house hold or environmental, 
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industrial intoxication. The toxic effects of any chemical is such an extensive subject 
that the clinician must pay attention to it, to prevent, recognize, treat those deleterious 
effects. 
   Our Siddhars paid more attention to herbs and also jeevam as they were used 
in curing diseases and also in alchemy. Hence I select “Poonaga Parpam” is mainly 
used in Spermatogenesis activity. Evaluation on safety aspects using scientific 
parameters is essential to cope up with the growing scientific world. Poonaga Parpam 
is commonly used in Male infertility like Impotence, Oligospermia etc.  
  A scientific evaluation is the need of the hour for this common medicine 
which is used extensively. This study will provide a scientific evidence for the safety 
of “Poonaga Parpam” to be used clinically. 
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2. AIM AND OBJECTIVES 
AIM: 
         The main aim of this study is to access the safety of the drug “POONAGA 
PARPAM” on  wistar albino rats under various dose levels of drug administration 
especially in acute and sub acute  toxicity studies.  
 
OBJECTIVE: 
 To collect the literature and other evidences of each ingredient on 
pharmacological and toxicological aspect.  
 To collect and purify the raw drugs according to literature evidence.  
 To prepare the medicine based on the procedure quoted in literature.  
 To establish the acute and sub acute toxicity of the drug. 
 To evaluate the biochemical analysis of the drug. 
 To analysis the haematological  investigations and histopathological study 
of the organs such as kidney, liver, heart and brain in wister rats. 
 To create an awareness among the practitioners of siddha to go for further 
study regarding the adverse effect in the drug.  
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3.REVIEW OF LITERATURE 
SIDDHA ASPECT 
POONAGAM 
NAME: 
  Poonagam 
ZOOLOGICAL NAME: 
  Lumbricus terrestris 
OTHER NAME: 
Olgk<kqe<!uqf<K!uqtr<G!sR<sQuqkie<!
hisk<kqe<!Osikq!hVuqb!er<gT!
figk<kqe<!hil<H!fzlie!h,lq!Out<!
Ohis!vskQhe<!h,figh<!OhVOl!
  The other names of earth warm megathin vinthu, sanjeevi, sothimayamana 
vethi,mangulathan,poomi vear,aagasatheepan. 
.!sm<jm!Leq!fqg{<M!
Nakku poochi, poomi vear, naangool puzhu, mansumantha vasugi, kandapatham 
.!G{h<himl<!kiK!sQu!uGh<H!
“H,figl<!kiee<Xl<!h,jxg<!gizq!
ohVk<kfqz!Ouove<Xl<!h,sq!hioee<Xl<!
%figl<!OgihE!vk<k!\f<K!!
Gtlie!h,zkisf<!kigR<!sqk<kq!
fifigl<!likk<K{<m!gLgiGf<!
fe<jlbie!us<sqv!fz<!l{qBliGl<!
Oufigl<!uqmr<gotz<zil<!Ohig<gq!jug<Gl<!
uqMhm<m!h,fig!uquvliOl’’/!!
.!Ohigi<!fqg{<M!
  Naangoozh, poonagam,  poomivear, megathin vinthu, pooraikaali, nilaveer, 
poosipan, ratha senthu, pooladhasam,  nanagam, thundagam, purudotha senthu  
 
PREPARATION OF EARTH WORM: 
  Dig the gravel land at one feet inside the hollow the millet husk should be 
placed. Then spit the water on the husk. Later cover the hollow with mat and coconut 
sheath, the water should be spit everyday at one time it should be continued for 10 
days or one week. Finally the earthworm will be produced. 
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TYPES OF EARTH WORM: 
dhqk<kqmOu!h,figl<!uqkl<!ov{<miGl<!
d{<jlbig!gVkq!Ohiozie<X{<M!kiOe!
ye<XkiOe!outqxqe!Okii<!squh<HliGl<!
dbi<f<kqm<m!squh<hK!kie<!dk<k!lf<kie<!
he<X!kiOe!sk<Kg<Gh<!hzqk!olik<k!
hir<gie!vsibek<!kQheqB!liGl<!
uqe<X!kiOe!outqxqe!Okii<!squh<H!kiEl<!
Ole<jlbie!lVf<Kg<G!fqkqBliGl</!
  Earthworm was obtained from marshland. It is of two types. The bright red 
colored was used for chemical purposes and the one which was pale red in color was 
used for preparing medicines. Of the two types, bright red colored was the best. They 
contain copper content.    
 
PURIFICATION OF EARTH WORM: 
Nole<x!Le<!osie<e!h,figf<kie<!
Ntf<K!Olkie!hcobie<X!hizqz<Ohim!
uiole<x!l{<o{z<zir<!gg<Gr<!gQOp!
lXfit<!kie<!njkobMk<Ks<!sm<cbqzqm<M!
Ofole<x!fQi<!uqm<Mg<!gPuq!Ohim<M/!
  The poonagam were put into cow’s milk. Let the poonagam to drink the milk 
and to vomit out the mud ingested by them then they were taken out and washed in 
the running water. 
 
GENERAL CHARACTERISTICS: 
likuX!osb<uxm<sq!liXlmr<!gis<sf<kq!
hikuX!OfiObiM!hiXlmz<!uikuiX!
G{<mhklQA!Olg<gie!jlbLl<!Ohir<!
g{<m!hk!ole<Xr<!giz</!
     Poonagathal migavum thunbathai vilaivikinra thaga rogam ( bilious diseases), 
Ezhu vitha asathiya sannipatha surangalum pogam ( Typhus Fever ). Oorusthamba 
vatham (numbness of thigh) engira mahavathamagiya puliyinal kavarnthu kollapatta 
thodaiagiya uruppu meezhuvathodu okkalamum kaphanoiyum olyum enga. 
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USES OF EARTH WORM: 
 Purified earth worm is dried and powdered and taken about 12.6g with 
grape juice for kidney stone. 
 Earth worm powder is mixed with Terminalia cattapa, ghee and it is 
applied for parturition pain, hydrocoele. 
 Earthworm is boiled with gingely oil and taken for chronic cough and 
throat pain. 
 Earthworm taken with meat soup increases the aphrodisiac activity. 
 Earth worm and dried leech is taken in equal ratio boiled in gingelly oil 
and it is applied on male external genitalia to increases aphrodisiac 
activity. 
 Earthworm is used externally for cut and bleeding wounds. Earthworm and 
black stone is made into paste and applied for joint dislocation and induces 
inflammation.  
 
H,fig!osf<K~vl<;< << << < !
!! Olivqzqm<M! Sk<kq! osb<k! H,figk<jk! NMkQ{<mih<hijts<! siX! uqm<M!
njvk<K!21!Hmlqm<omMg<g!osf<K~vl<!NGl</!
!! -kje! Ge<xq! ntuqz<! kg<g! Kj{lVf<kqz<! ogiMk<K! uv! Svl<!
G{liGl</!
!
H,fig!gVg<G!GcfQv<;< Q << Q << Q < !
!! H,figl<! 46! gqvil<?! lbqzqxG! 9/86! gqvil<! -ju! -v{<jmBl<! HKs<!
sm<cbqzqm<Mg<! gVg<gq?! nkqz<! sqxqktU! Oke<! uqm<M! 611! lqzq! fQv<! Osv<k<K!
nkEme<!Wzg<gib<!Okiz<!9/86!gqvil<!%m<c!fizqz<!ye<xib<g<!GXg<gqg<!gijz?!
lijz!ogiMk<K!uv!fiuxm<sq?!sf<fqOkiml<!fQr<Gl</!
!
H,fig!gVg<G;<<< !
!! H,figl<?!lbqzqxG!-v{<jmBl<!sloejm!wMk<K!sm<cbqzqm<M!sil<hzig<gq!
761! lqgq! Okeqz<! Gjpk<K! fiuqz<! gijz! lijz! kmuq! uv! fiuxm<sq?!
sf<fqOkiml<!fQr<Gl</!
!
H,figs<!sk<K;< << << < !
!! Ofv<f<kK!Ouv<!Nm<Ms<!sieqkt<tq!Ozkie<!
Ouole<x!H,figl<!kjeh<!hqjsf<K!
uqz<jz!OhiOz!-Ozsigh<!h{<{qmiOb!
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h{<{qBOl!lqMg<gie!oubqzqz<!Ohim<M!
hif<klig!Uzv<k<kqOb!kie<!le<!uqpilz<!
H{<{qbOl!ohVl<!hi{<mk<!keqz!juk<K!
ohVR<!sm<cbiz<!&c!l{<j{s<!osb<K!
 f{<{qBOl!hiz<!sill<!wvqk<k!hqe<H!!
gVkqbOkiv<!sil<hozz<zil<!gpzU,uOki!
gpzOukie<!sil<hozz<zir<!gjvk<kq!Xk<K!!
gelie!osl<ohz<zi!lcbqz<!fqx<Gl<!
lpz!Oukie<!Olz<!sil<hz<!-Xk<Kh<!Ohim<M!
lqe<ezig!osl<H!Ohiz!bcbqz<!fqx<Gl<!
gpzOukie<!S,koliV!hzf<kie<!Ohim<M!
KpiuqmOu!osl<ohz<zil<!hqck<Kg<!ogit<Tl<!
dpzOu!kie<!dV{<jm!Ohiz<!uir<gqg<!ogi{<M!
yg<gOu!kie<OhiM!gqxlVf<jkg<!OgOt!
.Ohigv<!8111!)&e<xilibqvl<*< < << < << < < !
!! hizqz<! Sk<kq! osb<k! 2! hc! )3zqm<mv<*! H,figk<jk! Ol]s<! )Nm<M*!
si{qbqzqm<Mh<! hqjsf<K?! sqX! uqz<jzgtib<s<! osb<K?! oubqzqz<! dzv<k<kqh<!
hi{<mk<kqzjmk<Ks<! sm<c! ogi{<M! &cs<! sQjz! l{<! osb<K! 23! l{q! Ofvl<!
wvqk<K! Nx! uqm<Mg<! gic! uiv<k<K! jgbiz<! hqjsf<K! gjvk<K! sil<hz<! fQjv!
-Xk<K!uqm<miz<!osl<hqe<!sk<K!ncbqz<!kr<Gl</!-vsl<!46!gqvil<!Ohim<M!Kpiu!
osl<H! hx<xq! dV{<jmbiGl</! -kjeg<! Gjgbqzqm<M! our<givl<! ogiMk<K!
dVg<g! -vsl<! hvq{lqk<K! uqMl</! osl<H! lik<kqvl<! dVgqk<! kr<Gl</! -kje!
osf<K~vl<!Lkzqbeuigs<!osb<K!dhObigqg<gzil</!
.G{himl<!kiK!\Qu!uGh<< Q << Q << Q <H/!
H,figs<!S,v{l<;< << << < !
H,figl<!! ! .!2!hzl<!
K~Kujt!sLzl<!! .!2!hzl<!!
kqvqgMG! ! .!¼!hzl<!)ujgg<G*!
kqvqhzi! ! .!1/8!hzl<!)ujgg<G*!
sqx<xvk<jk!! ! .!2/9!hzl<!
gx<gmgsqr<gq!! .!2/9!hzl<!
&r<gqZh<H!! ! .!2/9!hzl<!
sQf<kqz<!ogic!! .!2/3!hzl<!
!! wMk<K!dzv<k<kq!S,v{qk<K!sl!wjm!sQeig<gx<g{<M!ohic!gzf<K!wMk<K!
hk<kqvh<hMk<kUl</!
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ntU!! ;!! 2.3!gqvil<!
kQVl<Ofib<! ;!! gisl<?sbl?<!Ge<ll<?!-vk<kgisl<?!S,kguiB?!!
!! ! ! Olg!dm<{l<!kQVl</!
.!svOhf<kqvv<!sqk<k!lVk<Kus<!Smv</< < < < < << < < < < << < < < < < !
H,fig!hx<hl<;< << << < !
!! figv!u{<M!YM!7!hzk<kqx<G!sg<kqs<sivj{!siX!uqm<M!fe<G!njvk<K!
&jsBl<!&cBl<!osb<Kzv<k<kq!nkqz<!Sk<kq!osb<k!H,figl<!4!hzlqm<M!&c!yV!
sm<cg<Gt<!juk<K!Olz<!&c!sQjz!l{<!osb<K!5!sill<!wvqg<g!hx<hliGl</!
ntU!! ;!! h{oujm!uQkl<!!
Kj{lVf<K!;!! kqvqgMG?!Oke<!
kQVl<Ofib<! ;!! Svl<?!sf<fq!kQVl</!
.!Okjvbv<!juk<kqbl</< < << < << < < !
H,fig!hx<hl<;< << << < !
yV!uQs<js!squf<k!H,figl<!ogi{<M!uf<K!Olivqz<!Ohim<M!l{<o{z<zil<!
gg<gqe! hqe<H! Sk<klig! nzl<hqg<! gibjuk<K! -ck<Kg<! gz<uk<kqzqm<M!!
NMkQ{<mihijts<! siX! uqm<M! yVfit<! njvk<K! uqz<jz! osb<K! oub<bqzqz<!
dzv<k<kq!ngzqz<!-m<M!sQjz!osb<K!211!uvm<cbqz<!Hmlqm!hx<hliGl</!
!! ntU!! ;!! Oujtg<G!½!Lkz<!2!Ge<xq!wjm!-VOujt!26!fit<!!
Kj{lVf<K!;!! ofb<?!Oke<!
kQVl<Ofib<! ;!! ogicb!gisl<?!OlgSvl<!kQVl</!
hk<kqbl<! ;!! slbk<Kg<Ogx<h!nxqf<K!hk<kqblqVk<kz<!fzl</!
.!sqgqs<sivk<e!kQhl< < Q< < Q< < Q << <<!
!! H,figk<kqeiz<! kigl<?! sf<fqhikl<?! DV^<kl<huikl<?! uzq?! -sqU?!
ghOfib<gt<?!G{liGl</!H,figk<Kme<!sqxqK!Wzvqsq!Osv<k<kjvk<K!wMk<k!gx<gl<!
hig<gtU!uQkl<!ogiMk<K!uv!uzq!-sqU!kQVl</!
!! -k<Kme<! ofis<sqbqjz! Osv<k<kjvk<K! fz<oz{<{bqz<! gzf<K! jkz!
hklig!gib<s<sq!Gck<!jkzlig!!upr<g!l{<jm!Gjms<sz<?!gPk<K!fvl<Hgt<!
-sqU?!sQktk<kqeiz<!Wx<hm<m!kjzuzq?!kjzhivl<!kQVl</!
.nEhu!juk<kqb!Okuvgsqbl<!)Lkz<!higl<*< < < << < < << < < < !
nbk<kr<gs<!osf<K~vl<;< < < < << < < < << < < < < !
nbl<  .28!½!gqvil<!
kr<gl<! .28!½!gqvil<!
H,figl<! .28!½!gqvil<!
!! -ux<jxh<! Ohb<g<! gVl<Hs<! six<xqz<! ofgqp! njvk<K! uqz<jz! km<c!
oubqzqz<!gibjuk<K!ngzqz<!juk<K!Olz<!&c!sQjz!l{<!osb<K!yV!ohvqb!
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sm<cg<Gt<!hikqbtU!dh<Hg<!ogim<c!nke<!Olz<!ngjz!juk<K!OlZl<!dh<Hg<!
ogim<c! Olz<! sm<cg<! ogi{<M! &cs<! sQjz! osb<K! 23! l{q! Ofvl<! Lk<kQbqm<M!
wvqg<g!dbv<f<k!osf<K~vl<!NGl</!
ntU!! ;!! Ge<xq!wjm!-VOujt!!
Kj{lVf<K!;!! Oke<,!ofb<!!
kQVl<!Ofib<gt<;!! Gtqv<Svl<?!fQvqpqU!
.!svOhf<kqvv<!sqk<k!lVk<Kus<!Smv</< < < < < << < < < < << < < < < < !
H,fig!hx<hl<;< << << < !
!! Sk<kqk<k!H,figl<!Okjubie!ntU!wMk<K!yV!gzbk<Kt<!Ohim<M!Olz<!
ngz<! &c! sQjz! osb<K! oub<bqzqz<! dzv<k<kq! gzsk<kqe<! 31! hr<G! wjm!
uxm<cbqz<! Hmlqm<M! Nxqb! hqe<! wMg<g! hx<hliGl</! -kje! wMk<K! ohick<Kk<!
K{qbqz<!ucgm<c!htqr<G!Gh<hqbqz<!hk<kqvh<hMk<kUl</!
ntU!! ;!! 3.5!Ge<xq!wjm!
Kj{lVf<K!;!! Oke<?!ofb<?!ou{<o{b<?!sv<g<gjv?!fQv</!
kQVl<Ofib<gt<!;!! ghOfib<gt<!G{liGl</!ktv<f<k!fvl<Hgt<!LXg<Ogxq!!
hzh<hMl</!uqf<K!outqh<hiM!fQr<Gl</!
.!nEOhig!juk<kqb!fufQkl<!9l<!higl</< Q < < << Q < < << Q < < < !
fim<hm<m!-Vlz<!kQv;< < < Q< < < Q< < < Q !
w{<o{xbqx<!H,fig!olvqk<kqm<cm!fim<hMlqVlz<!
G{<{kqx<!Ohiz!GXgqbK!
!! fz<oz{<o{bqz<!H,figk<jk!sqjkk<Kh<!Ohim<M!gib<s<sq!hkk<kqz<!-xg<gq!
juk<K!ucgm<c!-Xk<K!juk<K!nkqz<!gv{<c!uQkl<!4?6?8!fim<gt<!Gck<K!uv!
fim<hm<m!-Vlz<?!-jvh<H!Lkzqbe!fQr<Gl</!
.!juk<kqb!ohVr<Gxt<!< < << < << < < .939!
H,fig!osbfQv<;Q <Q <Q < !
-f<Kh<jh!H,figk<kqx<!X~u!osbfQvib<!
uf<K!hbr<!gjvg<G!lkqz<!!
!! fig<GH,s<sqjb!yV!hik<kqvk<kqz<!Ohim<M!nke<!Olz<!ogiR<sl<!-f<Kh<jh!
K~uq!uqmUl</!nK!k{<{Qvib<!gjvf<K!osbfQvigq!uqMl</!
!! Olx<hc!osbfQv<!¼!ligi{!hc?!Ouh<oh{<o{b<!¼!ligi{!hc?!&m<Mk<!
kqvq!&e<X!wMk<K!wMk<K!-ux<jx!fe<G!gib<s<sq!hkk<kqz<!-xg<gUl</!uivl<!yV!
Ljx!ogiMg<g!-jth<H!-Vlz<!kQVl<!
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H,fig!gVg<Ggqbipl<< << << <!
 kQVl<!Q <Q <Q < Ofib<gt<< << << <! ;! uzqh<H?!dmz<!uxm<sq!
ntU!! ! ;! 41lq!!
! ! ! ! ! .!hkiIk<k!G{uqtg<gl<!
  
 fiBVuq!gVg<G!gqbipl<< << << <: 
  kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! njek<K!ujgbie!dmz<!uxm<sq 
ntU!! ! ;! 41!lq 
      - gqbip!-zl<hgl<!
H,fig!Olx<H,s<S!jkzl<< < << < << < <!
dhObigl<<<<! ! ;!! oux<xqjzbqz<!kmuq!hikqg<gh<hm<m!-mk<kqz<!!
hx<XOhim!Ou{<Ml</!
! kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! fvl<H!kti<s<sq?!dmz<uzqU!
.!nEOhig!juk<kqb!fufQkl<!
 H,fig!jkzl<!<<<  
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;!! fvl<H!kti<s<sq?!dmz<uzqU 
ntU!! ! ;! 6!–!21!Ktqgt<!
.!nEOhig!juk<kqb!fufQkl<?!higl<.4 
H,fig!kqzi!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! fvl<H!dvlig<gq 
ntU!! ! ;! 631!lqgq!
.!nEOhig!juk<kqb!fufQkl<?!higl<.4 
le<lkOzig!osf<K~vl<< < << < << < <!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! dmz<ue<jl?!dmz<!sg<kq?!fvl<H!dvlig<gq 
ntU!! ! ;! 286!–!321!gqvil< 
.!nEOhig!juk<kqb!fufQkl<?!higl<.2 
fiuxm<sq!gqbipl<< << << <!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! kigl<?!uqg<gz<?!fiuxm<sq?!fiuqz<!SvSvh<H 
ntU!! ! ;! 41lq!  
.!sqgqm<si!vk<e!kQhl<!
H,fig!$v{l<<<<!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! kigl<?!Olg$jz?!sbl<?!Osijh 
ntU!! ! ;! 3/:!gq 
.!sqgqm<si!vk<e!kQhl<!
! !
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Htqh<H!liKjt<<< !
 
Tamil name  :  Htqh<H!liKjt!
Botanical name : Purica granatum.Linn 
OuXohbi<! ! ;! kicll<?!hQsHvl<?!liKtr<gl<?!liKtl<?!!
liKTr<gl<?!gPLt<!
Eng   : Pomegranate 
Tel   :  Danimna 
Arab   : Rumaman 
Mal   : Mathlam 
Pers   : Gulmarn 
Kan   : Dalimba 
Hin   : Anae 
Sans   : Shukhdana 
Dak   : Darim 
!
liKjt!
! -K! sqX! lvuGh<jhs<! Osi<f<kK/! Lg<gqblib<! Nh<gieq^<kie<?!
ohZsq^<kie<?! hivsQgl<! Lkzqb! -mr<gtqz<! ntUgmf<K! utVgqe<xK/!!
-f<kqbiuqz<!wz<ziuqmr<gtqZl<!hbqiqmh<hm<M!uVgqxK/!!)-kqz<!-eqh<H!likjt?!
Htqh<H!likjt?!H,likjt!we<X!&e<X!uGh<HgT{<M/*!!!!!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
hbe<hMl<!dXh<H;< < << < << < < !!!
!! H,?!hqR<S?!hpl<?!uqjk?!hm<jm?!hpk<Okiz</!
 
ORGANOLEPTIC CHARACTERS 
hm<jm<<< !
Sju!)Taste)   - KuIh<H!)Astringent) 
ke<jl!)Potency)  - km<hl<!)Coolent) 
hqiqU!)Bio transformation)  - giIh<H!)Pungent) 
hpl<!uqjk<<< !
  Sju!)Taste)   - -eqh<H!)Sweet) 
ke<jl!)Potency)  - km<hl<!)Coolent) 
hqiqU!)Bio transformation)  - -eqh<H!)Sweet) 
! !
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osb<jg<<< !
Astringent - Kui<h<hq! ! .!! ^r<Ogisegiiq!
Styptic  - GVkqh<ohVg<gmg<gq!!-!! vk<k^<kl<hegiiq!
H,?!hpk<Okiz<< << << <!
Astringent - Kui<h<hq! ! .!! ^r<Ogisegiiq!
Stomachic - hsqk<kQk<K~{<c! .!! \mvig<equi<k<kqeq!
lvh<hm<jm!Oui<h<hm<jm< < < < << < < < << < < < < !
Anthelmintic - HPg<ogiz<zq!! .!! gqVlqfisqeq!
hpl<<<<!
Refrigerant - Gtqi<s<sqB{<mig<gq! .!! sQktgiiq!
uqjk!
Astringent -  Kui<h<hq! ! .! ^r<Ogisegiiq!
Anthelmintic - HPg<ogiz<zq!! .! gqVlqfisqeq!
Toenifuge - sibOlx<xq!
Aphrodisiac - N{<jlohVg<gq!
uQiqbl<!!! .!! k{<jl!)Gtqi<s<sq*!
k{<jl!uQiqbk<kqe<!okipqz<< Q < < << Q < < << Q < < <!
! leg<gtqh<H?! NBt<uqVk<kq?! kl<hel<! Ngqb! giiqbr<gjts<! osb<Bl</!!
-vk<kl<!hqk<kl<!Ngqbux<jxh<!Ohig<Gl</!
  T.V. sil<hsqul<! hqt<jt! nui<gt<! likjtbqe<! ujggjth<! hx<xq!
hqe<uVliX!%xqBt<tiI/!
! ! ! ! ! ! )T.V.S. !ngvikq!higl<!.!6!h/w{</:17*!
!
1. H,!likjt! ! ! .!! A male variety of pomegranate 
3/ Htqh<H!likjt! ! .!! Which beals only soul fruits; !
fruits useful in  vomiting.!!!
3. kqk<kqh<H!likjt! ! .!! Which bears only sweet fruits, fruits are  
used as tonic. 
4. ogic!likjt!)sQktr<gib<*!.!! A variety of citrus. 
5. ogil<lm<c!likjt! ! .!! A variety of citrus. 
6. kiK!likjt?!same as H,!likjt!.!Punica granatum 
8/ ubz<!likjt!
8. out<jt!likjt! ! .!! One with white pulpy seeds 
9. sQjl!likjt!! ! .!! Cynodia vulagaris 
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10. kic!likjt!! ! .!! Punica Granatum 
11. 11. squh<H!-vm<jm!likjt!.!  A male variety of pomegranate 
!
liKjt!H,!
G{l<<<<!
!!! -keiz<!GVkquif<kq?!ubqx<Xg<gMh<H?!ouh<hl<?!GVkq&zl<!-ju!OhiGl</!
-K!GVkqjb!ohVg<Gl</!!ue<jljbk<!kVl</!
! !
“uif<kqhqk<k!OkimoliM!lixig<!gMh<hezR<!
! Osi<f<Kfqe<x!&zvk<kf<!kQIg<Gr<gi{<!.!lif<ktqi<g<jg!
liOk"!bqvk<kH]<c!uz<zhze<!d{<miGl<!
H,kzk<Kt<!likjtbqe<H,” 
hqR<S<<< !
-keiz<!gpqs<sz<!ujggt<!biUl<!OhiGl</!
! “lzg<gpqs<sz<!sQkk<kiz<!uf<k!gpqs<sz<!
! szg<gpqs<sz<!Osiiqbix<!giVl<!.!hzg<gpqs<sz<!
! liTl<!Htqh<hie!liKtl<!hqR<jsB{<{!
! NTl<g{<!liOk!Nxq”!
hpl<<<<!
“liKjtg<!geqB{!lkegi!OlSvk<!
$oke!uiBti<!osiz<Zui<!lqg<gOu”/!
ohiVt<;<<< !
! liKtl<! hpk<jkk<! kqeLl<! Hsqk<Kuiqe<?! N{<jlh<! ohVg<G! Lkzqbe!
d{<miGl</!
!! -h<hpk<kqeiz<!Lh<hq{q!Svk<kqz<!gi{<gqe<x!uif<kq?!fQIOum<jg?!-jugt<!
OhiGl</!hqt<jt!d{<migilx<hc!osb<gqe<x!$zgOfijbh<!Ohig<Gl</!!ne<xqBl<!
uib<fQi<! Dxz<?! uqg<gz<?! lf<kl<?! ouh<hk<kiz<! d{<mie! gib<s<sz<! ofR<osiqU?!
gikjmh<H?!lbg<gl<!-ju!OhiGl</!!OlZl<?!dmz<!Gtqi<s<sqbjmBl<!Olx<%xqb!
h{<Hgjth<!ohxk<!kieigh<!hPk<K!ouck<k!liKjtbqe<!Lk<Kgjt!wMk<Kk<!
K{qbqzqm<M! hqjsf<K! sioxMk<K! Ou{<cb! ntU! gx<g{<M! %m<c! dmOe!
Gck<kz<!Ou{<Ml</!
! “sr<jgbxs<!osix<xuqi<g<GR<!se<eqbi!sR<si<k<kq!
! Br<jgbkq!gikjls<!siVOli!–!gr<jg!
! -Vf<kic!lg<gm<!gqvk<kjzs<osb<!Ofib<Ohil<!
! -Vf<kic!lg<geqgm<!og{<”!
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! “uib<fQV!xz<gsh<H!uif<kquqg<gz<!lf<klqg<g!
! gib<ouh<hl<!ofR<osiqU!gikjmh<Hl<!.!Ybi!
lbg<GLf<!kQIf<KuqMl<!liKtl<!hpk<kiz<!
kbg<glxk<!OkolipqOb!gix<X”/!
!
!! H,ju!dzi<k<kqs<! $v{qk<K!nkqz<! 5gq! wMk<K! Ouzl<! hqsqe<! K~t<! 5gq?!
nhqe<! 2:6lqgq! Osi<k<K?! Oujtg<G! 371.4:1! uQkl<! ogiMk<K! uv! sQkg<gpqs<sz<?!
GVkqg<gpqs<sz<?!GVkqfQI?!-vk<k&zl<!-ju!fQr<Gl</!
! hqR<jsg<! GcfQiqm<M! sQkOhkq?! nkqsivl<! LkzqbjugTg<Gl<! ogiMh<hK!
fim<M!upg<gl</!
!! )u/G*;! -ke<! hps<six<xqz<! gx<g{<M! Osi<k<K! l{h<hiG! osb<K! nVf<k?!
npjzh<!Ohig<Gl</!!Gtqi<s<sqjb!d{<M!h{<[l</!!Svl<?!npz<?!kigl<!-ju!
fQr<Gl</!
 hps<six<jx! -jth<H! Ofibqei<g<Gg<! ogiMg<g?! lqGf<k! fe<jl! kVl</!!
G{k<kqe<!gQp<g<g{<m!Ofib<gjt!uqzg<Gl</!
 hpk<OkiZme<! sqxqK! -zur<gl<?! -zur<gh<hm<jm?! fSg<gq! Ohim<M!
Ljxh<hc! GcfQiqm<M! 26.41! lqzq! uQkl<! kqel<! 4.5! Oujt! ogiMk<K! uv!
fim<hm<m!sQkg<gpqs<sz<!fQr<Gl</!!hpk<Okiz<?!lr<G^<kie<!hpk<Okiz<!hijz!
lvh<hm<jm! ujgg<G! 51gq! wMk<K?! 2511! lqzq! fQI! uqm<M! Ljxh<hc!
GcfQiqm<M!nkqz<!26.41!lqzq!ogiMg<gzil</!
 OlZl<! hzuqkg<! gpqs<sz<gTg<G! Kui<h<H! lVf<K! Ou{<cbkibqVg<Gl<!
OhiK!-jk!ogit<tzil</!
 hpk<Okijz!dzi<k<kqh<!ohicbig<gq!upr<gzil</!
 hpk<Okiz<!ohic!28!gq!out<jth<!Ohitl<!28gq?!sQjls<!S{<{il<Hk<K~t<!
45gq!Osi<k<K!gzf<K!hz<Kzg<g?!hz<uzq!OhiGl</!
 Oui<h<hm<jm!yVhr<G?!fQI!-VhK!hr<G!uqm<M!sqxqK!-zur<gl<!Osi<k<K?!
wm<cz<!ye<xig!gib<s<sqg<!ogiMg<g?!km<jmh<HP!uqPl</!
!
“ouck<KuQp<!hpk<jk!uir<gq!olz<zqb!sQjz!gm<c!
gMg<ogeh<!hqpqf<K!ogi{<M!g{<mgi<g<!gjvBr<!%m<cg<!
Gck<kqm!ouch<H!liXr<!Gtqi<f<kqMl<!nr<golz<zil<!
! uck<kkfe<!olipqbq!eiOt!liKtl<!hpk<kqe<siOx”!
u/G/! H,! olig<jg! dzi<k<kqh<! ohick<K! –! 241lqgq! ogiMg<g! -Vlz<!
fQr<Gl</!
! !
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liKtl<!hqR<Sg<!GcfQi<< < < Q << < < Q << < < Q <!
! “Lgli!Kjth<hqR<!skquqmbl<!Lk<kg<!giS!ohVlvk<Okiz<!
! kjgOsi<!Sg<G!uqtr<gibqe<!sjkObi!ovie<X!gpR<sqv{<M!
! ujgbib<g<!%m<c!bqVfipq!Bpg<gib<g<!gib<s<sqh<!OhikVf<f!
! hjgbib<!uVlkqsivSvl<!OhiGl<!hiiqx<!hiiQOv”!
ohiVt<!
! liKtl<! hqR<S?! nkquqmbl<?! Lk<kg<giS?! ohVlvk<Okiz<?! Sg<G?!
uqtir<gib<k<kjs! -ju! yu<ouie<xqZl<! -v{<cv{<M! gpR<SgotMk<K! ye<X!
Osi<k<K?!-v{<M! fipq! fQI!uqm<M!njk!dpg<gib<g<!GXg<gqg<!Gcg<g?! gpqs<sz<?!
Svl<!hxf<K!OhiGl</!
liKtl<!hqR<S< << << < !
 Olx<hc! ohicBme<! Wzg<gib<k<K~t<?! gsgsik<K~t<?! Gr<gqgzqbk<K~t<!
Yovjm!Osi<k<K?!76lq/gq!ntU!kqel<!-VOujt!ogiMk<K!uv!fim<hm<m!
ohVr<gpqs<sz<?!sQkg<gpqs<sz<!-ju!fQr<Gl</!
 H,uqe<! siXl<! nXgl<Hz<zqe<! siXl<! Yovjm! Osi<k<Kg<! ogiMg<g!
&g<gqzqVf<K!GVkq!ucuK!fQr<Gl</!
 Olx<%xqb!H,juBl<!Hz<jzBl<!GcfQiqm<M!ohiiqk<k!our<givl<!sqxG!%m<c?!
uib<!ogih<Htqk<K!uvk<!oki{<jmOfib<!fQr<Gl</!!-kje!26.41lqzq!uQkl<!
gijzbqz<!ouXl<!ubqx<xqz<!-v{<M!l{qg<ogiV!kmjubig!NXkmju!
Gck<Kg<! ogi{<Om! uf<K?! gjmsqk<! kmjubqz<! gpqs<sjz!d{<mig<Gl<!
lVf<Kgjtg<!ogiMg<g!HP!outqbiGl</!
 Olx<hc! GcfQjvg<! Gpf<jkgTg<G{<miGl<! -Vlz<! Ofib<?! g{<Ofib<?!
ohiqbui<gTg<G{<miGl<! fim<hm<m! Svl<?! Ljxs<Svl<?! l{<{Qvz<! kihqkl<!
-jugtqeiZ{<miGl<!GVkqbpz<!Lkzqb!Ofib<gTg<Gl<!upr<gzil</!
dhObigl<!)nEOhig!juk<kqb!hqvl<lvgsqbl<!3.l<higl<!h/w{</374*!
!! yV! liKtl<! hqR<jsg<ogi{<M! uf<K! Olz<Okiz<! fQg<gq! nkqe<!
dt<tqVg<Gl<! uqjkjb! sih<hqm<M! uv! nkqsivl<! ):*! l<! kQVl</! Neiz<! 21!
fijtg<G! sih<hqm! Ou{<Ml</! ! Olx<osie<e! hqvgivl<! hpk<jks<! sih<hqm! hqk<kl<?!
kigl<?!ghl<?!uif<kq!-jugt<!kQVl</!
liKtr<GcfQI< Q< Q< Q !
! “liKtr<!gml<H!He<gqe<!uib<k<kOkui<!kqh<hqzq!bk<kqk<!
! kQkXr<!ogiPf<K!Sg<Gkqiqhjzuq!Gl<hqg<!%m<c!
! fQkqbi!bqv{<M!fipq!fQVpg<!gig<gqg<!ogi{<miz<!
! $kqje!LjzbqeiOt!Svlkq!sivl<!OhiOl”!
! !
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ohiVt<<<<!
! liKtl<?! gml<H?! He<G! ! -ux<xqe<! Oui<gt<?! kqh<hqzq?! nk<kqg<ogiPf<K?!
Sg<G?!kqiqhjz!Ngqb!-ju!yu<ouie<jxBl<!yOv!wjmbqz<!Osi<k<K!5!zqm<mi<!
fQIuqm<M!njk!2!zqm<mvigs<!S{<m!juk<K!nVf<kqz<?!Svg<gpqs<sz<!kQVl<!)Okve<.
F~X*!
liKtl<hm<jm< << << < !
!! hm<jms<siX!28!gqvil<!ogiMg<g?!nK!ubqx<Xh<!HPjug<!ogiz<Zl</!
uqjk!
! uqjkbieK!fQIk<Kh<Ohie!ouf<fQjv!-Xg<Gl</!!out<jtbqz<!gi[l<!fQI!
gMh<jh!fQg<Gl</!!-u<uqjk?!dmx<G!Dm<mk<jkBl<!N{<jljbBl<!d{<mig<Gl<!
hzuqk!-Ozgqbr<gtqz<!OsVl</!
! “Sg<gqzk<jk!gm<Mlf<ks<!Sg<gqzOki!ml<Ohig<Gl<!
! ng<g{Ol!gg<gMh<jh!Nx<Xr<gi{!–!wg<giZr<!! !
! OgiKek<ok{<!{iklzi<g<!ogil<hjtb!liOkosl<!
! liKtk<kqe<!hQs!uzq”!
liKjt!lvk<kqe<!Oui<!hqR<S< < < << < < << < < < !
! liKjt!Oui<?!hqR<S!-jgtqeiz<!uif<kq?!nkqsivl<!fQr<Gl</!!hpk<kqeiz<!
kiK?! N{<jl! uqVk<kq! d{<miGl</! ! kigl<! OhiGl</! ! -jz?! gib<?! lzi<!
-jugtqeiz<!Lx<%xqb!Ofib<gt<!biUl<!uqzGl</!
! “liKjtOui<!hqR<sqjug<G!uif<kqbkq!Svl<Ohil<!
! kiKUlil<!ng<gqeqg<Gk<!kigl<Ohil<!.!$jkfqgi<!
! ue<eLjz!bib<!-jzgib<!lilzi<g!Tg<GLeR;!
! osie<eju!obzil<!OhiGR<!osiz<”!
liKtl<hpk<kqe<!YM!)< < << < << < < Punica Granatum – Dried rind) 
 “sQvig<Gl<!uib<h<H{<j{s<!sQkLme<!vk<koleh<!
! Ohvig<Gl<!Ohkqgjth<!OhSr<giz<!.!Ofvig<Gl<!
! kiKOl!Ozir<Gl<!keqbik!kiglXl<!
! liKtk<kqe<!fx<geqk<Okiz<!li{<H”!
G{l<;<<< !
!! liKtl<hpk<kqe<! Olx<Oxizqeiz<! uib<h<H{<! sQkOhkq?! vk<kOhkq!
Lkzqbjugt<!Ohil</!!kiK!hzh<hMl<!we<g/!
osb<jg<<< !
! sr<Ogisegiiq?!uqbkiOhkgiiq!
! !
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dhObigqg<Gl<!Ljx< << << < !
!! dzi<f<k!liKtl<hpk<kqe<!Okijz!-ck<K?!3!½!'hib<!wjm!$v{k<jk!
yV!hpgqe!lm<GMjubqz<!Ohim<M!½!hc!szl<!uqm<M?!26.31!fqlq]l<!ogikqg<g!
juk<K! ucgm<c! juk<Kg<ogi{<M! Oujtg<G! 2.2!½!nUe<^ <! uQkl<! kqel<! 4!
Oujt!dt<Tg<Gg<! ogiMk<K!uvs<! sQkOhkq?! vk<kOhkq!Lkzqbjugt<! OhiGl</!!
-f<kg<! gqbipk<jkg<! ogi{<M! uib<! ogih<htqk<K! uv! uib<h<H{<?! lVf<Kgtqe<!
uQxqeiZ{<mie!uib<!Oug<giM!Lkzqbjugt<!G{liGl</!
liKtl<!hqR<S< << << < !
! “lzg<gpqs<sz<!sQkk<kiz<!uf<k!gpqs<sz<!
! szg<gpqs<sz<!Osiiqbix<!siVl<!.!hzgpqs<sz<!
! liTl<!Htqh<hie!liKtl<hqR<!sizbqjz!
! biTr<g{<!liOk!bxq”/!
G{l<<<<!
! HtqliKtl<!hqR<siz<!lzl<?!sQkl<?!szl<?!vk<kl<!-jugtqeqxlig!Ngqe<x!
hx<hz!nkqsiv!Ovigr<gt<!kQVl</< < Q << < Q << < Q < !
osb<jg<<< !
! sr<Ogisegiiq?!uqbkiOhkgiiq!
dhObigqg<Gl<!Ljx< << << < !
!! Htqh<Hs<! SjujbBjmb! liKtl<! hqR<js!dzi<k<kq! nke<Olz<! Okijz!
-ck<Ks<! $v{l<! osb<K! juk<Kg<! ogi{<M?! Oujtg<G! 21.26! Ge<xq! wjm!
kbqiqz<! gzg<gqg<! ogiMg<g! sQkOhkq?! vk<kOhkq?! fqui<k<kqbiGl</! ! -ke<!
hqR<Sg<gijb! njvk<K! yV! sqX! wZlqs<sr<gib<h<! hqvli{l<! kbqiqz<! gzg<gqg<!
ogiMg<gs<!sQkOhkq?!vk<kOhkq!Lkzqbjugt<!G{liGl</!!Htqh<H!liKtl<!hqR<S!
gqjmg<gik! slbk<kqz<! sikiv{! liKtl<! hqR<jsg<! ! %mh<! hqvObigk<kqz<!
Osi<k<Kg<ogit<tzil</!
liKtl<!H,<<< !
“uif<kqhqk<k!OkimoliM!lixig<!gMh<hezR<!
! Osi<f<Kfqe<x!&zvk<kf<!kQIg<Gr<gi{<!.!lif<ktqi<g<jg!
liOk!gjxh<H]<c!uz<zhz!!E{<mig<Gl<!
H,kzk<Ke<!liKjtbqe<H,” 
G{l<!
! liKjtbqe<! H,! hqk<kuif<kq?! ubqxjtkz<?! ouh<hl<?! vk<k&zl<!
-jugjth<!Ohig<Gl</!!vk<kh<!H]<cjbBl<!hzk<jkBl<!kVl</!
osb<jg<<< !
! sr<Ogisegiiq?!uqbkiOhkgiiq!
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dhObigqg<Gl<!Ljx< << << < !
! liKtl<! H,?! liKtl<! hqR<S?! liKtl<! ktqi<! -jugjtk<!
keqk<keqbiguiuK! )n*! yV! lqg<gs<! OsIk<kiuK! njvk<Kk<! kbqiqz<! gzg<gqg<!
ogiMg<g!vk<kOhkq?!sQkOhkq!Lkzqbjugt<!OhiGl</!
liKjt!uqk<K! –! sq/! g{<[silq! hqt<jt?! hkiIk<k!G{uqtg<gl<!&zui<g<gl<!
h/w{</!6:4?6:5*!
G{l<<<<!
! -eqh<Ht<t!liKtl<!uqk<kieK!Sg<gqzk<jk!-Xg<GuKf<!kuqv?!nkqZt<t!
Gx<xk<jkBl<!hqvOlgs<!SXg<jgBl<!fQr<Gl</!
osb<jg<<< !
! sr<Ogisegiiq!
dhObigqg<Gl<!Ljx< << << < !
! -kjeh<! hSuqe<! hiz<uqm<M! njvk<Kh<! hizqz<! gzg<gqs<! sih<hqm!
Olgg<gMh<H?!Sg<gqz!f]<ml<!Lkzqbux<jxh<!Ohig<GuKme<!lzk<jkg<!gm<Ml</!
!
likjt!OsVl<!lVf<Kgt<< < << < << < <!
2/!S{<jmux<xz<!< < << < << < < $v{l<<<<!
! S{<jmux<xz<?! gxqOuh<hqjz?! lil<hVh<H?! Yll<?! ofz<zqux<xz<?!
liKtl<hpk<Okiz<?!ouf<kl<!.!2!higl<!
osb<Ljx<<< !
! Olx<%xqb!svg<Ggjtg<!gibjuk<K?!hqxG!-tuXh<hib<!uXk<K!fe<xig!
-ck<Kh<!ohick<K!szqk<K!jug<gUl</!
ntU!
! 2.3!gqvil<!
Kj{lVf<K<<< !
! wVjlk<kbqi<!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <!
! ohiVlz<?! lf<kl<?! -jvs<sz<?! gpqs<sz<?! wVuib<! &jtOfib<?!
ohVr<gpqs<sz<?!fq{g<gpqs<sz</!
.!Okjvbi<!giqsz<!411!h/w{</99!
3/!liKjtofb<;!<<< !
.!sqgqs<sivk<kqe<!kQhl<!)g{<[silq!hqt<jt*< < < Q < < << < < Q < < << < < Q < < < !
ntU!;!!!
!! 2!giS!wjm!–!3Oujt/!
!
!
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kQVl<!Ofib<gt<Q < < <Q < < <Q < < <!
! sujzbqeiOzEl<?! g{s<$m<ceiOzEl<?! OuX! wg<giv{k<kqeiOzEl<!
fiTg<G! fit<! -jtk<K! OkiZl<! wZl<Hligg<! gi{h<hMl<! lg<gtqe<! Okgl<!
ogiPjljbf<K!4!likk<kqx<Gt<!wz<OzijvBl<!Ns<siqbh<hMl<!hcs<!osb<Bl</!
!
hk<kqbl<;< << << < !-s<sihk<kqbl<!
!
4/liKjt!l{h<hiG<<< !
! “gx<g{<Ml<!he<eQI!geqli!KjtvsLl<!
! fx<OxEr<!%m<cOb!fim<Muib<!.!osix<hlz<z!
! hi{<M!ouTk<koziM!hikr<!gvoliqkz<!
! li{<MOhi!ole<xiI!lgqp<”!
! gx<g{<M?! he<eQI?! liKjt! -vsl<?! Oke<! -jugjt! ye<xigg<! %m<cg<!
gx<g{<M! gjvf<k! hqe<! ucgm<c?! nMh<hqzqm<Mg<! ogikqg<g! juk<Kh<! hiGhkl<!
uf<kUme<! -xg<gq! Hm<cbqz<! njmg<gUl</! ! ntUh<hc! ogiMg<g! hi{<M?!
ouTg<Gl<!Ofib</!jggiz<!wiqU?!uif<kq!-jugt<!kQVl</!
!
5/!Wzikqs<!$v{l<!)svOhf<kqvi<!sqk<klVk<Kus<Smi<!h/w{</668?!669*< < < < < < < < << < < < < < < < << < < < < < < < < !
ntU!! ! ;!! ouVgcbtU!)-VOujt*!
nEhiel<<<<! ! ;!! kib<h<hiz<?!Oke<?!hps<siX?!liKtl<!hps<siX!
kQVl<Ofib<gtQ < <Q < <Q < < !<< <<! ;!! wiqUme<!-vk<kl<!uVkz<?!kiguxm<sq?!Osihl<?!!
uif<kq?!hqk<kl<?!kjzuzq?!n^<kqs<Svl<?!uiB?!!
=jt?!-Vlz<?!dh<hqsl<?!ofR<osiqU!!
Lkzqbe!G{liGl</!
!
6/!Jr<gibs<!$v{l<!)svOhf<kqvi<!sqk<klVk<Kus<Smi<!h/w{</66:?!671*< < < < < < < < < << < < < < < < < < << < < < < < < < < < !
ntU!! ! ;!! 3!Lkz<!6!gqvil<!)3!Oujt*!
nEhiel<!<<< ! ! ;!! Oke<?!si<g<gjv!
kQVl<Ofib<gt<Q < < <Q < < <Q < < <!! ;!! nsQv{Ohkq?!gqvi{q?!ubqx<Xh<Hsl<?!!
ng<gqeqlf<kl<?!d]<{Ohkq!Lkzqb!!
Ofib<gt<!G{liGl</!
hk<kqbl<< << << <! ! ;! Ofibqe<!ue<jlg<Ogx<h!gR<sq?!Hex<higl<?!!
ohiiqgR<sq! Ohie<xjugjtOb! ogiMg<g!
Ou{<Ml</!givl<?!Htq!Osi<g<gg<%miK/!
!
!
!
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7/!ghims<!$v{l<!))svOhf<kqvi<!sqk<klVk<Kus<Smi<!h/w{</671?!6< < < < < < < < << < < < < < < < << < < < < < < < < 72*!
ntU!! ! ;!! ouVgcbtU!)3!Oujt*!
nEhiel<<<<! ! ;!! Oke<?!hjeouz<zl<!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! gqvi{q?!nkqsivl<?!ubqx<Xjts<sz<?!gpqs<sz<?!!
-jvs<sz<?!sqXGmz<?!ohiVlz<?!kigl<?!Osigl<!
Lkzqbe!G{liGl</!
8/!lke!giOlSvs<!$v{l<!)svOhf<kqvi<!sqk<klVk<Kus<Smi<!h/w{</!692!< < < < < < < < << < < < < < < < << < < < < < < < < .!695*!
ntU!! ! ;! ouVgc!ntU!)3!Oujt*!
! ! ! ! ! 2!l{<mzl<!)59!fim<gt<*!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;! Olgoum<jm?!kiKfm<ml<?!uiksQktl<?!!
Gjms<sz<?!Lmg<gl<?!hqk<kl<?!uif<kq?!
lzhf<kl<?!uiB?!uikl<?!Ge<ll<?!Olgl<?!
&zg<gqvi{q?!hi{<M?!uq]higr<gt<?!
Gtqi<Svr<gt<!Lkzqbe!G{l<!njmBl</!!
uQiqb!uqVk<kqbiGl</!
!
9/!gm<Muikqs<$v{l<!)Ogi< < << < << < < ]ibq!nEOhig!juk<kqb!hqvl<l!vgsqbl<!h/w{</217*< < < << < < << < < < !
ntU!! ! ;!! 2!uvigoejm!
kQVl<!Ofib<gt<Q < < <Q < < <Q < < <! ;!! nkqsivl<!.!7?!sQkOhkq?!!
gqvg{q!22!G{liGl</!
!
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MODERN ASPECT 
EARTHWORM 
MODERN ASPECT 
  Earth worms have been used in medicine for various remedies since1340A.D 
(Stephenson 1930). Describing earth worm Darwin notes "Earth worm is nature’s 
wonderful creation. This unnoticed and unimportant small creature does such a useful 
and enormous job that we become dumbfound".   
  Dr. Berrett says, "The skeleton of earth worm's body has no structure but still 
it contains all the wonders of culture". 
  The use of earth worms as therapeutic drug is described in a book on ancient 
Chinese Medicine "shen Nong's Herbal". According to traditional Chinese medicine, 
earth worms possess anti pyretic, anti-spasmodic, diuretic and detox effect etc. In 
recent years it has also been found that earth worms have strong anti-asthmatic and 
anti-allergic effects (Mac et. a1 1964).  
  According to the description given by vohora and Khan (1978) earth worm 
have largely been used internally and externally as powerful aphrodisiacs. Internally 
there are useful in chronic cough, diphtheria and jaundice and for facilitating delivery. 
Earth worms increase body heat and are of value in rheumatism, bronchitis, nerve 
disorders and tuberculosis.  
  Poonagam is being used in siddha Medicine very succesfully for many years. 
An intensive literary collection was done through books and discussions made with 
eminent scholars of science. According to our Siddha and Modern literature, 
Poonagam mainly indicated in the disease of chronic cough, hemiplegia and 
rhematism.  
Tamil Name   : Poonagam 
English Name  : Earth Worm  
Zoological name  : lumbricus terrestris 
 
SYSTEMIC POSITION  
Phylum   :  Annelida  
Class    :  Clitellata  
Order    :  Lumbriculida 
Family   : Lumbricidae 
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Genus    :  lumbricus   
Species   :  terrestris 
 
DISTRIBUTION: 
  It is cosmopolitan in distribution. It is found abundantly in Europe, India, 
Srilanka, and north pacific. 
 
HABITAT AND HABIT: 
  Lumbricus terrestris can inhabit all soil types except coarse sands, bare rock 
and acidic peat (Sphagnum).  It has been found to be constrained by the -15°C 
isotherm.  It tolerate soils with pH values as low as 3.5 – 3.7 and as high as about 
8.L.terrestric is not frost-tolerant indicating that it hibernates in deep soil layers during 
the winner (Addison, 2009; Tiunov at al., 2006; Wironen & Moore, 2006).  Although 
often present in agricultural fields, it fares poorly due to herbicides, mechanical 
damage and lack of leaf litter (L.Frelich, pers.comm.) 
 
SHAPE AND SIZE: 
   The body is long, narrow, slender, bilaterally symmetrical, tapering posteriorly 
and relatively broad anteriorly, it is approximately dorsoventrally flattened with 
rounded dorsal surface  and flat ventral surface.it may range from 30-40 cm in length 
and 2-6 mm in width. 
 
COLOUR: 
      The colour of the worm is red or yellowish brown. The colour may also vary 
even in the individuals of same species of different age and sexual maternity. 
 
SEGMENTATION: 
     The anterior end is differentiated into a distinct head and the rest of the body is 
divided by a series of segments arranged in a linear series. 
 
EXTERNAL MORPHOLOGY: 
  The prostomium of lumbricus bears a pair of small tactile tentacles and a pair 
of stout palps. On the dorsal surface of the prostomium are two pairs of black eyes 
lying directly over the brain. Each eyes is a cup of modified epidermal cells, the ends 
of which extended through a black pigment layer to form a retinal lining of light 
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sensitive rods. The cavity is filled with a lens , protruding from the cup as a spherical 
swelling covered by a transport layer of skin, the cornea, the periosteum of lumbricus 
is actually two segments fused together. The body may be divided into as many as 
200 segments. 
 
BODY WALL: 
  It provides definite shape to the body (due to its elasticity).  Moist body wall 
helps in respiration.  Protects the internal delicate organ from injury.  Secrete mucus 
which keeps body surface slimy and kills harmful bacteria.  Alternative contraction 
and relaxation of circular and inner longitudinal muscle helps in movement.  Albumen 
secreted by clitellar gland helps in nutrition of embryo developing inside cocoon.  
Sensory epidermal cells serve for reception of external stimuli. 
 
INTERNAL MORPHOLOGY: 
  The mouth opens into a muscular pharynx which occupies several segments. 
The pharynx leads to a tubular esophagus into which a pair of glandular digestive 
pouches opens. The rest of the digestive system in nereis is a simple long intestine 
ending at a short rectum in front of the anus. The blood collected in to a longitudinal 
dorsal vessel and distributed from a longitudinal ventral vessels. At the anterior end 
several pairs of commissures around the pharynx and esophagus connect the two 
vessels. The large bilobed brain is in the prostomium of  lumbricus. Many small 
nerves extend to all parts of the anterior end of the body. 
 
HOW THE EARTH WORM SQUIRMS ALONG: 
  One set of muscles runs the length of the body. The other set runs around the 
body. The worm can make its body longer by relaxing the long muscles and 
shortening the other ones.  
    It can shorten its body by pulling in the long muscles and loosening the 
others. To more forward, it grips the dirt with the bristles under the tail end of its 
body. Then it lengthens the body. This action pushes the head forward through the 
dirt, then the worm grips the dirt under its head and pulls up the tail end of its body. 
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ANALYSIS OF FRESH EARTHWORMS: 
  Analysis of fresh earthworms gave the following values 
    Water    : 79.86% 
    Protein   : 10-14% 
Fat    : 1.5% of the total fat 
Glyceridic   : 56% - 67% 
Phosphatidic   : 44 -33 %  
Unsaponifiable matter : 50% 
  Unknown acids in addition to fatty acids of the C10 – C22 series 
 Ergosterol 
 Cholesterol 
 Stigmasterol 
 Flavin  
   The chief end product of the nitrogen metabolism was adenine. A yellowish 
amorphous substance which cause haemolysis in dilution of  1:8000 and a 
bronchodialating principle have also been isolated from earthworm. 
 
A Vital Component of Traditional Chinese Medicine: 
  In China and other parts of Asia, earthworms are also used for their medicinal 
properties. Earthworms are caught, killed and then eviscerated, with the viscera and 
organic components washed away. The worms are then dried for use.  
  According to the concepts of traditional Chinese medicine, earthworm is 
associated with the Bladder, Liver, Lung and Spleen meridians, and has salty and cold 
properties. It drains liver heat and clears lung heat, and can also clear heat in the 
collateral channels. Typically, earthworm is used with other herbs to treat a wide 
range of conditions, ranging from spasms and convulsions to pain relief, treatment of 
fevers and certain types of arthritis. It is also used to treat some types of asthma and 
bronchitis.  
  The average recommended dose of earthworm is 4.5 to 12 grams per day as an 
oral decoction. Larger amounts (10-20 grams) are used when fresh earthworms are 
employed. As a powder, 1-2 grams are recommended for oral use.  
Dried, powdered earthworm can be found at some Asian markets and specialty stores. 
Earthworm is also available as a decoction, usually as part of a larger herbal formula.  
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  Because earthworm has a strong taste that can invariably be salty, “fishy” or 
both, it may cause nausea and even vomiting in some sensitive individuals. This can 
be countered by taking earthworm powder, or taking earthworm with citrus fruits or 
other herbs. In addition, some patients may experience allergic reactions to 
earthworm. It also should not be taken by Women who are pregnant or lactating. As 
of this writing, there are no known drug interactions with earthworm. As always, 
make sure to consult with a licensed health care provider before taking earthworms or 
any other herbal remedies or dietary supplements.  
 
EARTHWORM TO REMOVE BLOOD CIRCULATION IMPEDIMENT : 
 A survey Chinese have used earthworms for thousand of years modern 
scientific research has found out why, it contain three thrombolytic enzymes: 
fibrinolysin (plasmin) profibrinolysing  activator and collagenase which are all we 
need to dissolve thrombus and restore blood circulation  to the brain. 
 
Earthworms as Food in Different Cultures:  
  Earthworms have been used as food in many cultures. It is generally 
considered a delicacy and is reserved only for the most distinguished guests and the 
elderly. Now we know why.  
 
NEW DISCOVERY AND A NEW MEDICINE: 
   During to 70s professor Shanhongren discovered enzymatic functions of 
extract from earthworms which confirms the validity of the use of earthworms in 
traditional Chinese medicine. In 1997 a product named plasmin made from earthworm 
was approved by the chinese government as a new medicine. In 1997 plasmin was 
endorsed by the china geronotology foundation and a year later it was endored by the 
china geronotology association rehabilitation committee. In 1999 china medical 
society decided to make plasmin a key product to be promoted all over China. In the 
same year it was registered by the china supervisory and administrative bureau as a 
class two nationally protected TCM formula, and in 2000 it is included in the china 
national pharmacopoeia. 
 
TRADITIONAL USE OF EARTH WARMS: 
 Traditional Chinese medicine has been using earthworm (lumbrius) for 
thousands of years. The famous compendium materia medica describes, it as “ salty in 
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taste” cold in property, and efficacious in clearing the geart, invigorating blood 
circulation dissolving stasis, opening up channels, curing stroke, hemiplegia and 
infantile convulsion, and pointed out that lumbricus has self dissolving ingredients. 
 Modern scientific research, especially Prof.Shan’s finding, verified the 
Chinese use of earthworms after finding important enzymes in them.  
 
HOW IT WORKS: 
 Made of a special strain of earthworms with new biochemical, engineering 
technology, plasmin provides three thrombolytic enzymes; fibrinolysin (plasmin)., 
Profibrinolysin activator and collagenase, it is nontoic and good for long term use 
without any side effect. This enteric capsule carries plasmin into the intestines and 
opens up and is absorbed into blood circulation system. It helps to maintain a healthy 
balance between hemolysis and hemostasis, may help reduces the risk of ischemic 
cardiovascular problems,such as stroke, embolism, thrombus, arteriosclerosis, 
etc.,The risk of diabetic complications including nervous pathological changes and 
micro circulation disturbances, and maintain healthy arterial functions and promote 
blood circulation by opening up arteries and help to maintain a healthy cholesterol 
and blood sugar level, reduced blood fat. It also provides many trace elements and 
vitamins needed by the human body. 
 
EARTHWORM BENEFITS: 
 Improve the physical structure of the soil  
 Improve soil fertility  
 Improve plant growth and health  
 A large earthworm population suppresses weed growth  
 Worms often help clean up dangerous chemicals in the environment  
 Improve water absorption and prevent erosion  
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POMEGRANATE 
 
Botanical name   :  Punica granatum.Linn 
 According to Bentham & Hooker’s classification Punica granatum is classified  
as follows: 
Kingdom : Plant kingdom 
Division : Angiosperms 
Class  : Dicotyledons 
Sub class : Polypeptalae 
Series  : Calyciflorae 
Order  : Mystales 
Family  : Lythraceae 
Genus  : Punica 
Species : Granatum 
Vernacular names 
Hindi  :  Anar 
Beng  : Palim 
Mar  : Palimba 
Guj  : Dadam 
Tel  : Danimma 
Tam  : Madulai 
Kan  : Dalimba 
Mal  : Matalam 
Habitat 
 In moral tryst china, Afghanistan, Pakistan, Bangladesh, Iran Iraq, India, 
Burma, Spain, Moroko, Baluchistan, Arabia and California. 
 In India, Maharashtra, Gujarat, Rajasthan, Karnataka, Punjab, Haryana, 
Tamilnadu, Andra pradesh and Uttar Pradesh. 
 It is an attractive chrunb or small tree 6 to 10m tall, much branched, spiny and 
long lived.  It has strong tendency to sucker from the base. 
Leaves 
 Leaves are evergreen or deciduous, opposite or in words of 5-6 short stemmed 
oblong-calceolate and leathery. 
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Flower 
 Flowers are showy and characterized by the thick, tubular red calyx with 
pointed lepals.  The flowers are bright red, 3cm in diameter, with four to five petals 
(often more on cultivated plants) .  Some fruitless varieties are grown for the 
flowers alone.  The edible fruit is a berry and is between a lemon and a grapefruit in 
size 5-12cm in diameter with a rounded hexagonal  shape, and has thick reddish skin.  
The exact number of seeds in a pomegranate can vary from 200 to about 1400 seeds, 
contrary to some beliefs that all pomegranates have exactly the same number of seeds.  
Each seeds has a surrounding coater-laden pulp the edible aril-ranging in color from 
white to deep red or purple.  The seeds are embedded in a white, spongy, astringent 
pulp. 
Fruits 
 Fruits are round with a longly leathery skin, yellow, light or deep pink or dark 
red in colour.  The inner portion is separated by membranous walls and white spongy 
tissue into compartments packed with transparent sacs filled with flavorful, fleshy, 
juicy, red, pink or whitish pulp.  In each sac, there is one white or red, angular, soft or 
hard seed.  The aril around the seeds from the ediple parts consist of delicious juice. 
 
Actions:  
Flower and rind 
 Astringent 
 Stomachic 
Stem bark and root bark 
 Anthelmintic 
Fruit 
 Refrigerant 
- (G{h<himl<!&zqjg!uGh<H!h/w{</861*< < < << < < << < < < !
 
Uses 
 All parts of the tree can be utilized as source of tannin for curing leather. 
 Both the wind and the flowers yield dyes for textile.  The juice is rich in citric 
acid and sodium citrate and used in the treatment of dyspepsia and leprosy. 
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 The bark of the stem and root contains alkaloids like iso-pelletierine used 
against tape warms extracts of bark, leaves, imature fruits and fruit pind have 
been presecribed as astringent to half diarrhoea, dysentery & haemorrhages. 
 Dried pulverized flower buds are administered against bronchitis. Detection of 
flowers is gargled to relieve oral and throat inflammation. 
 Tracks of different parts of the tree exhibited antibiotic activity.  Extracts of 
whole fruit highly active against micrococcus pyogenesvar aureus, E.coli and 
pseudomonas aeruginosa. 
 Fresh pomegranate juice is used as an ingredient of cooling and refrigerant 
mixtures and of some medicines for dyspepsia. 
 The rind is valued as an astringent in cases of diarrhoea & dysentery. 
 The expressed juice of the leaves and the young fruit and the decoction of the 
bark are seed in dysentry. 
 In java, an ink is sometimes arade from infusion of the leaves in native in egar. 
 The sweet types of pomegranate said to be acidly laxative, white the less sweet 
types are believed to be good in inflammation of stomach and in head pain. 
 The powered flower buds are used in bronchitis.  The seeds are considered to 
be stomachic and the pulp cardiac and stomachic. 
                                                              Handbook of Edible fruits Pg. No.402-404 
In Ayurvedic medicine  
 The rind of the fruit and the bark of the pomegranate tree is used as a 
traditional remedy against diarrhoea, dysentery and intestinal parasites. 
 The seeds and juice are considered a tonic for the heart and throat and 
classified as a bitter-astringent (pitta or fire) component under the Ayurvedic 
system and considered a healthful counter balance to a diet high in sweet-fatty 
(kapha or earth) components. 
 The astringents qualities of the flower juice, rind and tree bark are considered 
valuable for a variety of purposes, such as stopping nosebleeds and gum 
bleeds, toning skin, (after blending with mustard oil) firming up sagging 
breasts and treating hemorrhoids, pomegranate juice (of specific fruit strains) 
is also used as eyedrops as it is believed to slow the development of cataracts. 
  Pomegranate has been used as a contraceptive and abortifacient by means of 
consuming the seeds, or rind as well as by using the rind as a vaginal suppository.  
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This practice is recorded in ancient Indian literature, in Medieval sources and in 
modern folk medicine. 
Potential health benefits  
  In preliminary laboratory research and clinical trials, juice of the pomegranate 
may be effective in reducing heart disease risk factors, including LDL oxidation, 
macrophage oxidative status and foam cell formation in mice, “oxidation of LDL by 
peritoneal macrophages was reduced by up to 90% after pomegranate juice 
consumption”. 
  In a limited study of hypertensive patients, consumption of pemegranate juice 
for two weeks was shown to reduce systolic blood pressure by inhibiting serum 
angiotensin converting enzyme.  Juice consumption may also inhibit viral infections 
while pomegranate extracts have antibacterial effects against dental plaque. 
  Despite limited research data, manufacturers and marketers of pomegranate 
juice have liberally used evolving research results for product promotion, especially 
for putative antioxidant health benefits.  In February 2010, the FDA issued a warning 
letter to one such manufacturer, POM wonderful, for using published literature to 
make illegal claims of unproven antioxidant and anti – disease benefits. 
Nutrients 
  That fiber, however, is entirely contained in the edible seeds which also supply 
unsaturated oils.  People who choose to discard the seeds forfeit nutritional benefits 
conveyed by the seed fiber, oils and micronutrients. 
Nutritive value (per 100gm of edible portion)  
– The pomegranate Pg.No.1 Author-M.K.Sherth 
Moisture : 78gm 
Protein  : 1.6gm 
Fat  : 0.10gm 
Minerals  : 5.10gm 
Phosphorus  : 0.07gm 
Iron  : 0.30gm 
Riboflavin : 100mg 
Vitamin C  : 16mg 
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Seeds 
 Astringent 
 Anthelmintic 
 Toenifuge 
 Aphoridisiac 
 
Climate & Soil   
 Pomegranate is basically a crop of acid and semiarid region and it requires hot 
dry summer and cold winter for production of quality fruits.  A temperature of 35 to 
38° is ideal for quality fruit production.  Cool winter and hot summer is favourable for 
this crop.  It can be grown in tropical and sub-tropical parts of North eastern hill 
region upto an attitude of 1000m from sea level.  In a sub-tropical climate, it flowers 
in the spring but in tropical climate it flowers through out the year.  However flowers 
of early rainy season give a quality in novermber-December. 
- (Wealth of India Pg.No.317) 
Propagation 
 Basal step cuttings with a diameter of 1.0 to 1.25 taken during rainy season 
and maximum success is achieved with the treatment of IBA at 5000ppm.  It is also 
propagated by air layering.  Air layering during rainy season and November-
December gives profuse rooting. 
 
Phytochemical study 
 Pomegranate arial juice provides about 16% of an adults’s daily vitamin C 
requirement pear 100ml serving, and is a good source of vitamin B5 
(Pantothenic acid) potassium and natural phenols, such as ellagitannis and 
flavonoids. 
 Analysis edible portion of pomegranates from coonoor give moisture-78.8, 
protein – 1.6, fat-0.4, fibre – 5.1, other carbohydrates 1405 & mineral matter 
0.7% calcium 18, magnesium 12, oxalic acid 14, phosphorus  78.6, Iron – 0.3, 
sodium – 0.9, potassium – 33.6, copper – 0.2, sulphur-12. chlorine-2.8, 
carptene-8, thiamine – 0.06, ribothamine-0.10, elicobinicacid – 0.30 & vit C – 
14 mg /100mg. 
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 The fresh rind of the fruit contains wax 0.8, resins – 4.5, mannitol – 1.8, non-
crystallized sugars – 2.7, gums – 3.2, insulin – 1.8, mucilage – 0.6, mannin – 
16.4, gallic acid – 4, calcium oxylate-4.8% 
 The following alkaloids have been reported as occuring in the bark,  
Pelletierine (C8H15ON) – isopelletierin (C8H15ON) Pseudopelletierine 
(C9H15ON) Methyl Pelletreuine (C9H17ON) & Methyl isopelletierine 
(C9H17ON). 
 D-Mannitol occurs abundantly in the stem bark and in lesser amounts in 
rootbark seeds & leaves. 
 Biological tests indicate that mannitol possess mild anti spasmodic & 
anthelminetic properties. 
 Frieldelin & betulic acid are reported in the bark, betulic and ursolic acid in 
the leaves and ursolic acid in the fruit kind. 
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LATERAL RESEARCH WORKS 
PHYTO-CHEMICAL STUDIES  
 Two new b-sitosterol esters have been isolated from the flowers of punica 
granatum Linn. (punicaceae) along with the known compounds n-tricosane(3), 
nheptacosanyln-hexanoate (4), olean-5, 12-dien-3b-ol-28-oic acid (5), and olean-12-
en-3b-ol-oicacid (6).  The structures of the new phyto sterols have been elucidated as 
stigmast – 5-en-3b-ol-3b-dodecanoate(6-sitosterollaurate, 1) and stigmast-5-en-3b-ol-
3b-tetradeconoate. 
 
PHARMACOLOGICAL ACTIVITIES 
ANALGESIC ACTIVITY 
 The extracts of flowers of Punicagranatum (Linn). (N.O.Family Punicaceae) 
were investigated for analgesic activity in mice using hot plate method.  The flowers 
of Punicagranatum (Linn) were collected from the local market of Mumbai, 
Maharashtra and were in a dried condition.  The dried powdered flowers (500gm) 
were extracted in a soxhlet apparatus by using different solvents mice weighing 15-
25gm were taken for the experiment.  The reaction time of animals in all the groups 
was noted at 30, 60 and 120 min after drug administration.  All data were analyzed 
with student-t-test.  The various extract of the flowers of punicagranatum (Linn). 
showed significant analgesic activity at a dose of 50mg/kg body weight.  A maximum 
analgesic activity was found at 60min, after drug administration, which was 
equivalent to the standared drug used as morphine sulphate. 
 
WOUND HEALING ACTIVITY 
 The present study demonstrated that Punicagranatum extract was capable of 
promoting.  Enhanced wound contraction and histological observations suggest that 
punicagranatum has potential in the management of wound healing and suggests 
further study. 
 
ANTI-SPASMODIC ACTIVITY 
 Our result indicated that aqueousand  hydroalcoholic extracts of 
punicagranatum flower could induce relaxant effects on uterus of virgin rat and 
uterine contractions were decrease without involvement of β-adrenoceptors or 
opioidreceptors.  These results indicate that aqueous extracts of punicagranatum 
flower could induces spasmolytic effect on rat uterus through blockage of VDCCs.  
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These results support the clinical efficacy and use of punicagranatum flower in the 
treatment of dysmenorrhoea and other uterine spasmodic disorders.  This process 
appears to be the most relevant physiological process and should be the target of 
future research. 
 
ANTI-DIABETIC ACTIVITY 
 Peroxisome prolifecator-activated receptor (PPAR)-gamma activators are 
widely used in the treatment of type & diabetes because they improve the sensitivity 
of insulin receptors.  Punicagranatum flower (PGF) has been used as an anti-diabetic 
medicine in unani medicinal literature.  The mechanism extract diminishes cardiac 
fibrosis in zucker diabetic fatty rats, atleast in part, by modulating cardiac ET-1 and 
NF-kappa B signaling of actions is, however, unknown.  In the current study, we 
demonstrated that 6-week oral administration of methanol extract from PGF 
(500mg/kg, daily) inhibited glucose loading-induced increase of plasma glucose 
levels in zucker diabetic fatty rats (ZDF), a genetic animal model for type 2 diabetes, 
whereas it did not inhibit the increase in zucker lean rat (ZL).  The treatment didnot 
lower the plasma glucose levels in fasted ZDF and ZL rats.  Further more, RT-PCR 
results demonstrated that the PGF extract treatment in ZDF rats enhanced cardiac 
PPAR-gamma MRNA expression and restored the down-regulated cardiac glucose 
transporter (GLUT)-4 (the insulin-dependent isoform of GLUTs) MRNA.  These 
results suggest that the anti diabetic activity of PGF extract may result from improved 
sensitivity of the insulin receptor.  From the in vitrostudies, we demonstrated that the 
PGF extract enhanced PPAR-gamma MRNA and protein expression and increased 
PPAR-gamma dependent MRNA expression and activity of lipoprotein lipase in 
human THP-1-differentiated macrophage cells.  Phytochemical investigation 
demonstrated that gallic acid in PGF extract is mostly responsible for this activity.  
Thus, our findings indicate that PPAR-gamma is a molecular target for PGF extract 
and its prominent component gallic acid, and provide a better understanding of the 
potential mechanism of the anti-diabetic action of PGF. 
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CARDIAC ACTIVITY 
 The diabetic heart shows increased fibrosis, which impairs cardiac function.  
endotholin (ET)-1 and nuclear factor-kappa B (NF-kappa B) interactively regulate 
fibroblast growth.  We have recently demonstrated that punicagranatum flower (PGF), 
a unani anti-diabetic medicine, is a dual activator of peroxisome proliferator-activated 
receptor (PPAR)-alpha and –gamma, and improves hyperglycemia, hyperlipidemia, 
and fatty heart in zucker diabetic fatty (ZDF) rat, a genetic animal model of type 2 
diabetes and obesity.  Here, we demonstrated that six-week treatment with PGF 
extract (500mg/kg, P.o) in zucker diabetic fatty rats reduced the ratios of van Gieson- 
stained interstitial collagen deposit area to total left ventricular area and perivascular 
collagen deposit areas to coronary artery media area in the heart.  This was 
accompanied by suppression of overexpressed cardiac fibronectin and collagen I and 
III MRNAS.  Punicagranatum flower extract reduced the up regulated cardiac MRNA 
expression of ET-1, ETA, inhibitor-kappa B beta and C-jun and normalized the down-
regulated MRNA expression of inhibitor-kappa Balpha in zucker diabetic fatty rats.  
In vitro, Punica granatum flower extract and its components oleanolic acid, cusolic 
acid and gallic acid inhibited lipopolysaccharide-induced NF-kappa B activation in 
macrophages.  Our findings indicate that punica granatum flower. 
 
HEPATO-PROTECTIVE ACTIVITY 
 PGF- treated ZDF rats showed reduced ratio of liver weight to tibia length, 
hepatic triglyceride contents and lipid droplets.  These effects were accompanied by 
enhanced hepatic gene expression of Peroxisome proliferator   -activiated receptor 
(PPAR) – alpha, carnitine palmitoyl transferase- 1 and acyl-COA oxidase (ACO) and 
reduced stearoyl – COA dsaturase – 1.  In contrast, PGF showed minimal effects on 
expression of genes responsible for synthesis, hydrolysis or uptake of fatty acid and 
triglycerides.  PGF treatment also increased PPAR-alpha and ACO MRNA levels in 
HepG2 cells. 
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HONEY 
 Honey is a naturally converted form of sugary food, the nectar of flowers and 
other plant exudations systemically collected and stored by honey bees. 
Honey as a vehicle: 
Physical properties of honey 
Aroma   : Depends upon the floral source from  
where it’s collected. 
Colour   : It ranges from pale yellow or yellowish brown  
to dark brown. 
Specific rotation :  +3 to -10 
Constituents of honey 
 Honey contains chiefly dextrose and fructose moisture, small amounts of 
sucrose and mineral constituents. 
 Moisture: 20.6% fructose: 38%  glucose : 31% sucrose: 1% other sugar 
8.5% fat: 0.1% minerals: 0.2% , Protein 0.3%  others: 0.4%. 
 Vitamins present in honey are vitamin B1-B6, Vitamin C. 
 Minerals include calcium, phosphorous and Iron. 
 Trace elements in honey arte magnesium, selenium, sulphur, chloride and 
silica. 
 Coloring matter: Caroline, chlorophyll, xanthophylls, anthocyanin, tanin.  
 Acids: Acetic acid, formic acid, malic acid, citric acid, succinic acid, 
oxalic acid. 
 Enzymes: Chief enzyme present in honey is invertase.  Other include 
protease, oxidases, peroxidase, reductase. 
      -The wealth of India Vol. II Pg.91) 
Action 
 Antimicrobial 
 Antiseptic 
 Sedative 
 Demulcent 
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Uses of Honey 
 Provides wholesome nourishment also an energy giving rich food. 
 The predigested sugars present in honey are easy to digest and are readily 
absorbed and assimilated by the body. 
 Extensively used in preparing breads, cakes, biscuits, pastries, chewing gums, 
candies. 
 Honey constitutes all important ingredients of certain lotions, cosmetics, 
soaps, creams, balms, inhalations. 
 
Distinguishing quality honey 
 High quality natural honey can be distinguished its fragrance and taste.  The 
honey should  not lay down in layers.  It this is a case, it indicates the excessive 
humidity (over 20%) of the product, and such a honey would not be suitable for long 
term preservation. 
 A fluffy thin layer on the surface of the honey (like a white foam) or marble-
coloured and white spots in crystallized honey at the wall sides of the bottle are 
caused by filling of liquid honey with subsequent sealing- the air bubbles are 
surfacing and part of them is concentrated at the wall sides.  This is an indication of a 
high quality honey, which was tilled without pasteurization (heating). 
 A true  honey that is at least one month old is usually of demure (not 
translucent) colour. 
 
Preservation of Honey: 
 Because of its unique composition and the complex processing of nectar by 
the bees.!
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INGREDIENTS OF  DRUG POONAGA PARPAM 
Purification process of Poonagam 
Purified Poonagam 
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INGREDIENTS OF  DRUG POONAGA PARPAM 
PULIPPU MATHULAI 
KAVASAM 
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DRUG PREPARATION 
PREPARED DRUG POONAGA PARPAM 
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4. MATERIALS AND METHODS 
Selection of drug: 
  Poonaga Parpam mentioned in Anuboga vaidhya navaneetham (Part – 3, 
Pg.No. 117,118, Hakim P. Mohamed Abdulla Sahib) was selected for evaluating the 
toxic effect and mortality  when given in short and long duration.  
Collection of raw drug: 
  The raw drugs were collected from Agricultural land at Sankarankovil through 
proper identification. 
Ingredients of poonaga parpam: 
 Poonagam 
 Sour pomegranate juice 
Purification of raw drugs: 
POONAGAM: 
  Poonagam soaked in milk for a day. Mud comes out from it.  
Then wash it in water. 
Method of preparation: 
  The purified drugs were taken in the following ratio. 
 Purified Poonagam  - 2 palam (70 gm) 
 Sour pomegranate juice          - S.Q 
  Purified poonagam was powdered and add sour pomegranate juice little by 
little. Grind for 2 Saamam and make cake pieces then dry it. Then it is placed into 
earthen plate and covered with another earthen plate, make 3 seelai and subjected into 
sublimation process by using cow dung, weight of twenty fold of kavasam.Then cool 
and obtain reddish shadow parpam and stored it in air tight container. 
Dosage: 
      2 – 4 Kunrimani edai (260-520 mg) 
Adjuvant: 
       Honey                
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5. QUALITATIVE AND QUANTITATIVE ANALYSIS 
PHYSICOCHEMICAL ANALYSIS 
 
 Sample Description  : POONAGA PARPAM 
 Equipment used  : Atomic Absorption Spectrometer (AAS) 
Colour: 
 About 50gm of POONAGA PARPAM was taken in a clean glass beaker and 
tested for its colour by viewing again a water opaque background under direct 
sunlight. 
 
pH: 
 The pH of POONAGA PARPAM was estimated as per the method prescribed 
in Indian Standard (IS) – 6940 (1982). One gram of the POONAGA PARPAM  was 
taken into a 100ml graduated cylinder containing about 50ml of water and filled up to 
the mark with water. The cylinder was stopped and shaken vigorously for two minutes 
and the suspension was allowed to settle for an hour at 250 to 270.  About 25ml of the 
clear aqueous solution was transferred into a 50ml breaker and tested for pH using 
DIGISUN digital pH meter ( DIGISUN Electronics, Hyderabad, India) 
 
Determination of Ash Value: 
 Weighed accurately 2 grams of POONAGA PARPAM in tarred platinum or 
silica dish and incinerate at a temperature not be exceeding 4500C until free from 
carbon, cooled and weighed. Calculate the percentage of ash with reference to the air 
dried drug. 
 
Water Soluble Ash: 
 To the gooch crucible containing to the total ash, added 25ml of water and 
boiled for 5 minutes. Collected the insoluble matter in a sintered glass crucible or on 
ash less filter paper. Wash with hot water and ignite in a crucible for 15 minutes at a 
temperature nor exceeding 4500 C  subtract the weight of the insoluble matter from 
the weight of the ash the difference of the weight represents the water soluble ash. 
Calculate the percentage of water soluble ash with reference to the air dried drug. 
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Acid Insoluble Ash: 
 Boiled the ash 5 minutes with 25ml of 1:1 dil HCL. Collect the insoluble 
matter in gooch crucible on an ash less filter paper wash with hot water and ignite. 
Cooled in a desiccators and weighted calculated the percentage of acid insoluble ash 
with reference to the air dried drug. 
 
Loss on Drying: 
 Five grams of POONAGA PARPAM is heated in a hot oven at 1050C to 
constant weight and the percentage of loss of weight has calculated there from. 
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PHYTOCHEMICAL ANALYSIS 
 
PROCEDURE 
Test for Alkaloids (Ansari, 2006)  
The extract was evaporated in a test tube. To the residue dilute HCL was 
added, shaken well and filtered.  
1.Mayer’s Test: 
  To the 2-3 ml of filtrate Mayer’s reagent was added. Formation of yellow 
precipitation showed the presence of alkaloids. 
Ansari, S. H. 2006.  
  Essentials of pharnacognosy, 1st edition, Birla publications, New Delhi. pp. 
357-359, 588-590. 
2.Dragendroff’s Test:  
  To 2 mg of the ethanolic extract 5 ml of distilled water was added, 2M  
Hydrochloric acid was added until an acid reaction occurs. To this 1 ml of 
Dragendorff’s reagent was added. Formation of orange or orange red precipitate 
indicates the presence of alkaloids. 
3.Hager’s Test:  
  To 2 mg of the ethanolic extract taken in a test tube, a few drops of Hager’s  
reagent was added.Formation of yellow precipitation confirms the presence of 
alkaloids. 
Test for Carbohydrates and Glycosides 
1.Molisch Test  
  2 mg of ethanolic extract was shaken with 10ml of water, filtered and the 
filtrate was concentrated. To this 2 drops of freshly prepared 20% alcoholic solution 
of α- naphthol was added. 2 ml of conc. sulphuric acid was added so as to form a 
layer below the mixture. Redviolet ring appear, indicating the presence of 
carbohydrates which disappear on the addition ofexcess of alkali. 
2.Legal’s Test 
  The test is employed for digitoxose containing glycosides. The extract of drug 
is dissolved in pyridine, sodium nitroprusside solution is added to it and made 
alkaline, pink or red color is produced.  
3.Borntrager’s Test 
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Borntrager’s test is employed for presences of anthraquinones. The drug is 
boiled with dilute sulphuric acid, filtered and to the filtrate benzene, or ether or 
chloroform is added and shaken well. The organic layer is separated to which 
ammonia is added slowly. The ammoniacal layer shows pink to red color due to 
presences of anthraquinone glycosides. 
Test for PhytoSteroids (IP, 1996) 
1.Salkowski Test:  
  To 2 ml of extract, 2 ml of chloroform and 2 ml of conc. H2SO4 was added. 
The solution was shaken well. As a result chloroform layer turned red and acid layer 
showed greenish yellow fluorescence. 
Indian Pharmacopoeia (IP). 1996.  
  Govt. of India, Ministry of Health and Family Welfare Published by the 
Controller of Publications, New Delhi, A-47, A-53, A-54. 
2.Liebermann-Burchard’s test 
  2 mg of dry extract was dissolved in acetic anhydride, heated to boiling, 
cooled and then 1 ml of concentrated sulphuric acid was added along the sides of the 
test tube. Formation of green colour indicates the presence of steroids. 
Test for Flavanoids (Kokate, 1994) 
Shinoda Test: 
To the extract, 5 ml of 95% ethanol and few drops of concentrated 
hydrochloric acid was added. To this solution 0.5 gm of magnesium turnings were 
added. Pink colouration indicated the presence of flavanoids. 
Kokate, C. K. 1994.  
  Practical Pharmacognosy, 4th edition, Vallabh Prakashan, New Delhi.  4 - 29. 
Test for Tannins (Mukherjee, 2002) 
Lead Acetate Test:  
  On addition of lead acetate solution to the extract white precipitate appeared. 
Mukherjee, P. K. 2002.  
  Quality control of herbal drugs, business horizons pharmaceutical publishers, 
New Delhi.  356 - 358. 
Saponin (Ansari, 2006) 
Foam Test:  
  Drug extract was shaken vigorously with water. No persistent foam was 
formed. 
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QUANTITATIVE ANALYSIS OF POONAGA PARPAM 
PROCEDURE: 
Quantitative Estimation of carbohydrate 
The total sugar content was estimated by Anthrone method (Roe, 1955). A 
known amount of the sample was taken, ground well with 80% ethanol and was 
centrifuged at 4000 rpm. From the supernatant, 0.5 ml was taken and 5 ml of anthrone 
reagent was added. The tubes were kept in a boiling water bath for 15 min. After that, 
they were kept in a dark room for another 15 minutes. The colour intensity developed 
was read in a spectrophotometer at 650 nm. 
  
Ref: ROE, J. H. (1955), “The determination of sugar in blood and spinal fluid with 
anthrone reagent” Ibid., ill: 335-343. 
 
Quantitative Estimation of flavanoids: (Evans, 1996) 
Total flavonoid content was determined by Aluminium chloride method using 
catechin as a standard. 1ml of test sample and 4 ml of water were added to a 
volumetric flask (10 ml volume). After 5 min 0.3 ml of 5 % Sodium nitrite, 0.3 ml of 
10% Aluminium chloride was added. After 6 min incubation at room temperature, 2 
ml of 1 M Sodium hydroxide was added to the reaction mixture. Immediately the final 
volume was made up to 10 ml with distilled water. The absorbance of the reaction 
mixture was measured at 510 nm against a blank spectrophotometrically. Results were 
expressed as catechin equivalents (mg catechin/g dried extract). 
 
Ref: Devanaboyina N et al., “Preliminary Phytochemical Screening, Quantitative 
Estimation And Evaluation Of Antimicrobial Activity Of Alstoniamacrophylla Stem 
Bark” IJSIT, 2013, 2(1), 31-39 
 
Quantitative Estimation of Saponins: (Evans, 1996) 
Methanolic and water extract was dissolved in 80% methanol, 2ml of Vanilin 
in ethanol was added, mixed well and the 2ml of 72% sulphuric acid solution was 
added, mixed well and heated on a water bath at 600c for 10min, absorbance was 
measured at 544nm against reagent blank. Diosgeninis used as a standard material and 
compared the assay with Diosgenin equivalents. 
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Ref: Devanaboyina N et al., “Preliminary Phytochemical Screening, Quantitative 
Estimation And Evaluation Of Antimicrobial Activity Of Alstoniamacrophylla Stem 
Bark” IJSIT, 2013, 2(1), 31-39 
 
Quantitative Estimation of Tannins: (Robert, E.B. 1971. Agro.J.63, p.511)  
1ml of the extract was mixed with 5ml of vanillin hydrochloride reagent (mix 
equal volumes of 8% HCL in methanol and 4% vanillin in methanol). The mixed was 
allowed to stand for 20mins and measure the absorbance at 500nm. The standard 
graph was plotted for working standard catechin solution (0 to 250µg/µl).  
 
Ref: Robert, EB, "Method for estimation of tannin in grain sorghum ", Agro J , 
vol. 63, 1971,p.511; 10. 
 
 
                                            
  
 FOURIER TRANSFORM 
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Fig. 3: FTIR Apparatus 
FTIR-Mechanism 
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FOURIER TRANSFORM – INFRA RED SPECTROSCOPY 
PERKIN ELMER – SPECFTRUM ONE 
Introduction 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular  structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can be 
assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular interactions, 
phase transitions and chemical kinetics can be carried out using this branch of 
spectroscopy. 
 In IR spectroscopy, the resonance absorption in made possible by the change 
in dipole moment accompanying the vibrational transition. The infrared spectrum 
originates from the vibrational motion of the molecule. The vibrational frequencies 
are a kind of fingerprint of the compounds. This property is used for characterization 
organic, inorganic and biological compounds. The band intensities are proportional to 
the concentration of the compound and hence qualitative estimations are possible. The 
IR spectroscopy is carried out by using Fourier transform technique. 
Principle 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction,l electromagnetic radiation characteristic 
of the interacting system may be absorbed (or emitted). The experimental data consist 
of the nature (frequency of wave length) and the amount (intensity) of the 
characteristic radiation absorbed or emitted. These data are correlated with the 
molecurlar and electronic structure of the substance and with intra – and inter 
molecular interactions. 
 FT-IR spectroscopy is used primarily for qualitative and quantitative analysis 
of organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave number is referred to as the finger print 
region. Absorption bands in this region are generally due to intra molecular 
phenomena and are highly specific for each material. The specificity if these bands 
allow computerized data searches to be performed against reference libraries to 
identify a material. 
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Table of Characteristic IR Absorptions 
Frequency, cm-1 Bond Functional group 
3640 - 3610 (s, sh) O-H stretch Free hydroxyl alcohols phenols 
3500 - 3200 (s,b) O-H stretch, H – bonded Alcohols, phenols 
3400 – 3250 (m) N – H stretch Primary, secondary, amines, 
amides 
3300 – 2500 (m) O – H stretch Carboxylic acids 
3330 -  3270 (n, s)  –C (triple bond) C – H : C  - H 
stretch 
Alkynes (terminal) 
3100 – 3000 (s) C – H stretch Aromatics 
3100 – 3000 (m) = C – H stretch Alkenes 
3000 – 2850 (m) C – H stretch Alkenes 
2830 – 2695 (m) H – C = 0; C –H stretch  Aldehydes 
2260 -  2210 (v) C (triple bond) N stretch Nitriles 
2260 – 2100 (w) C (triple bond) C- stretch Alkynes 
1760 – 1665 (s) C = 0 stretch Carbonyls (general) 
1760 – 1690 (s) C = 0 stretch Carboxylic acids 
1750-  1735 (s) C = 0 stretch Esters, saturated aliphatic 
1740 – 1720 (s) C = 0 stretch Aldehydes, saturated aliphatic 
1730 – 1715 (a) C = 0 stretch Alpha, beta – unsaturated esters 
1715 (s) C = 0 stretch Ketones, saturated aliphatic 
1710 – 1665 (s) C = 0 stretch Alpha, beta – unsaturat 
aldehydes, ketones 
1680 – 1640 (m) -C = C - Alkenes 
1650 – 1580 (m) N – H bend Primary amines 
1600 – 1585 (m) C-C stretch (in – ring) Aromatics 
1550 – 1475 (s) N – 0 asymmetric stretch Nitro compounds 
1500 – 1400 (m) C –C stretch (in – ring) Aromatics 
1470 – 1450 (m) N – 0 asymmetric stretch Nitro compounds 
1370 – 1350 (m) C – H bend Alkanes 
1360 – 1290 (m) C – H rock Alkanes 
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1335 – 1250 (s) C – N stretch Aromatic amines 
1320 – 1000 (s) C – 0 stretch Alcohols, carboxylic acids, 
esters, ethers 
1300 – 1150 (m) C – H wag ( - CH2X) Alkyl halides 
1250 – 1020 (m) C – N stretch Aliphatic amines  
1000 – 650 (s) =C – H bend Alkynes 
950 – 910 (m) O – H bend Carboxylic acids 
910 – 665 (s, b) N – H wag Primary, secondary amines 
900 – 675 (s) C – H “oop” Aromatics 
850 – 550 (m) C – CI stretch Alkyl halides 
725 – 720 (m) - C (triple bond) C-H : C- H 
bend 
Alkynes 
690 – 515 (m) C  - Br stretch Alkyl halides 
 
M = medium, w = weak, s=strong, n =  narrow, b = broad, sh = sharp 
 
Sampling techniques: 
 There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. 
 Solid : KBr or Nujol mull method 
 Liquid : CsI / TIBr Cells 
 Gas : Gas Cells 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36KBr Method 
 The Sample was grounded using – an agate mortar and pestle to give a very 
fine powder. 
 The finely powder sample was mixed with about 100 mg dried KBr salt. 
 The mixture was then pressed under hydraulic press using a dye to yield a 
transparent disc (measure about 13 mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed.  
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HR SEM - METHODOLOGY 
 
 
HR SEM-Methodology: 
 An SEM is essentially a high magnification microscope, which used a focused 
scanned collection beam to produce images of the sample, both top-down and, with 
the necessary sample preparation, cross-sections. The primary electron beam interacts 
with the sample in a number of key ways:- 
Primary electrons generate low energy secondary electrons, which tend to emphasize 
the topographic nature of the specimen. 
  Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast. 
  Ionized atoms can relax by electron shell-to-shell transitions. Which lead to 
either X-ray emission or Auger electron ejection. The X-rays emitted are 
characteristic of the elements in the top few urn of the sample. 
Sample Preparation: 
 Sample preparation can be minimal or elaborate for SEM analysis depending 
on the nature of the samples and the data required. Minimal preparation includes 
acquisition of a POONAGA PARPAM that will fit into the SEM chamber. And it 
should be analyzed. 
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES), 
 
Fig. 5: ICPOES  Apparatus 
 
ICP OES METHODOLOGY: 
 ICP, abbreviation for Inductively Coupled Plasma, is one method of optical 
emission spectrometry, When plasma energy is given to an analysis sample from 
outside, the component elements (atoms) is excited. When the excited atoms return to 
low energy position, emission rays that correspond to the photon wavelength are 
measured. The element type is determined based on the position of the photon rays, 
and the content of each element is determined based on the ray’s intensity. 
 To generate plasma, first, argon gas is supplied to torch coil, and high 
frequency electric current is applied to the work coil at the tip of the torch tube. Using 
the electromagnetic field created in the torch tube by the high frequency current, 
argon gas in ionized and plasma is generated. This plasma has high electron density 
and temperature (10000K) and this energy is used in the excitation –emission of the 
sample. Solution samples are introduced into the plasma in an atomized state through 
the narrow tube in the center of the torch tube. 
Sample preparation: 
  Solids cannot be analyzed directly. Such samples should be made into clear 
aqueous medium quantitatively. When acids are used to prepare solutions care should 
be taken. The concentration of the acids in the final provided solution should not be 
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more than 2% v/v. highly acidic and organic solutions cannot be analyzed. As a guide 
line weigh exactly, around 200mg of substance and dissolve in 5mL of 5% of water or 
aquaregia or whatever acid to make 100mL of final solution. Make proper dilutions, if 
necessary. Free HF should not present in the final solution to be aspirated. 
  Ideal concentration is around 100 ppm of the element of interest. Total 
dissolved solids should be not more than 0.2% w/v in the final solution Very dilute 
solution may not give reliable results. Each element has a detection limit. A minimum 
solution volume of 25 ml is necessary for analysis. 
In ICP intensity of light emitted when the sample “sprayed or aspirated into an argon 
plasma” is measured at different wavelengths. The intensity of light at a given 
wavelength will be proportional to a particular elemental ion concentration. The 
intensity is calibrated with known standard concentration. For accurate quantitative 
results It is necessary to simulate the sample matrix condition with that of the 
standard. Each element generally will have many emission lines and the sensitivity is 
different for each of this wave length. When more than one element is present it is 
quite common that some emission lines interfere due to overlapping. 
  It is preferable to use plastic containers for sample handling and preserving 
samples for ICP-OES analysis. Glass containers can give problems especially when 
analyzing certain metal ions at low concentration. 
  The samples of  POONAGA PARPAM was prepared. 
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BIOCHEMICAL ANALYSIS 
BIOCHEMICAL ANALYSIS OF POONAGA PARPAM: 
Preparation of extract: 
  100mg of parpam is weighted accurately and placed into a clean beaker added 
a few drops of conc.hydrochloric acid and evaporated it well. After evaporation 
cooled the content and added a few drops off concentrated nitric acid and evaporated 
it well. After cooling the content add 20ml of distilled water and dissolved it well. 
Then it is transformed it to 100ml volumetric flask and made upto 100ml with 
distilled water. Mix well. Filtered it. Then it is taken for analysis. 
Qualitative analysis:  
S.No. EXPERIMENTS OBSERVATION INFERENCE 
1. Test for calcium: 
2 ml 0f the above prepared extract 
taken in a clean test tube to this add 
2 ml of 4% ammonium oxalate 
solution. 
Formation of white 
colour  precipitate 
 
presence of 
calcium 
 
2. Test for sulphate: 
2 ml of the extract is added to 5% 
barrium chloride solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
sulphate. 
3. Test for chloride: 
The extract is treated with silver 
nitrate solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
chloride. 
 
4. Test for carbonate: 
The substance is treated with 
concentrated HCL. 
 
Formation of 
effervescence. 
 
presence of 
carbonate. 
5. Test for starch: 
The extract is added with weak 
iodine solution. 
 
Formation of blue 
colour 
 
presence of 
starch. 
6. Test for ferric iron: 
The extract is acidified with glacial 
acetic acid and potassium ferro 
cyanide. 
 
Formation of blue 
colour 
 
presence of 
ferric iron. 
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7. Test for ferrous iron: 
The extract is treated with 
concentrated nitric acid ammonium 
thiocyanide solution. 
 
Appearance of 
blood red colour. 
 
presence of 
ferrous iron 
8. Test for phosphate: 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
 
Formation of yellow 
precipitate 
 
 
presence of 
phosphate. 
 
9. Test for albumin: 
The extract is treated with esbach’s 
reagent. 
 
Formation of yellow 
precipitate 
presence of 
albumin. 
10. Test for tannic acid: 
The extract is treated with ferric 
chloride. 
Formation of blue 
black precipitate. 
presence of 
tannic acid. 
 
11. Test for unsaturation: 
Potassium permanganate solution 
is added to the extract. 
 
It gets decolourised. 
 
Presence of 
unsaturated 
compounds. 
12. Test for the reducing sugar: 
5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
add 8 to 10 drops of the extract and 
again boil it for 2 minutes. 
Colour change 
occurs. 
 
Presence of 
reducing sugar. 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1 %  ninhydrin 
is sprayed over the same and dried 
it well. 
Appearance of 
Violet colour 
 
Presence of 
amino acid. 
 
14. Test for zinc: 
The extract is treated with 
potassium  ferro cyanide. 
Formation of white 
precipitate 
Presence of zinc. 
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6. PRE-CLINICAL STUDIES 
TOXICITY STUDY 
TOXICOLOGICAL STUDIES ON POONAGA PARPAM 
OBJECTIVES 
 The aim of this study is to evaluate the toxicity of the drug  POONAGA 
PARPAM, when administered orally to male Wistar Albino Rats with different doses, 
so as to provide a rational base for the evaluation of the toxicological risk to man and 
indicate potential target organs. 
 
Guidelines followed: 
 OECD Guidelines No.423. 
 The experimental protocol was approved by IAEC (Institutional Animal 
Ethical Committee) as per the guidance of CPCSEA (Committee for the Purpose of 
Control and Supervision of Experiments on Animals), Ministry of Environment and 
Forest, Government of India. 
 
Study design and Controls: 
1) Wistar Albino Rats in controlled age and body weight were selected. 
2) POONAGA PARPAM was administered at 5mg/kg, 50mg/kg, 300mg/kg, 
2000 mg/kg body weight as water as suspension along with blank. 
3) The results were recorded on the day of drug administration approximately  
1st , 3rd , 4th, 24th hours in post dosing further made in to observation upto 14 
days. 
4) The animals were kept in a clean environment with 12 hour light and 12 hour 
dark cycles. The air was conditioned at 22 ±3ºC and the relative humidity was 
maintained between 30-70% with 100% exhaust facility. 
 
EXPERIMENTAL PROCEDURE 
Animals 
   Male Wistar albino rats (150 – 200 gm)  were used for the study. The animals 
were obtained from animal house, Kerala Veterinary and Animal Sciences, 
Mannuthy, Kerala. The animals were placed at random and allocated to treatment 
groups in polypropylene cages with paddy husk as bedding. Animals were housed at a 
temperature of 24±2oC and relative humidity of 30 – 70 %. A 12:12 light:dark  cycle 
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was followed. All animals were allowed to free access to water and fed with standard 
commercial pelleted rat chaw (M/s. Hindustan Lever Ltd, Mumbai). All the 
experimental procedures and protocols used in this study were reviewed by the 
Institutional Animal Ethics Committee, Nandha College of Pharmacy, Erode 
(688/PO/Re/S/02/CPCSEA) and were in accordance with the Institutional ethical 
guidelines (Proposal Number:NCP/IAEC/2018-19/23) 
Test Compound 
 Poonaga parpam  
Administration Procedure 
 Honey was used as vehicle and various doses of Poonaga parpam were 
administered through oral route using gastric gavage tubes to animals by suspending 
in vehicle.  
  The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
Table-1 Group Numbering and Identification animals were marking on body 
Group No Animal Marking 
1 Head 
2 Body 
3 Tail 
 
  The group no., sex of the animal and animal numbers were identified as 
indicated below using cage label and body marking on the animals. 
Table – 2 Numbering and Identification cage label and body marking                             
on the animals. 
Cage No Group No Animal marking Sex 
1 I H,B,T Female 
2 II H,B,T Female 
3 III H,B,T Female 
4 IV H,B,T Female 
5 V H,B,T Female 
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  The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighed and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
 
ACUTE TOXICITY STUDY 
Acute Toxicity Studies 
 Acute toxicity studies were performed according to OECD-423 (Organization 
of Economic and Cooperation Development) guidelines.  
  Male Wister albino rats were selected by random sampling technique were 
employed in this study. The animals were fasted for 4 hr with free access to water. 
The Poonaga parpam was administered orally at a dose of 5 mg/kg initially and 
mortality if any was observed for 3 days. If mortality was observed in two out of three 
animals, then the dose administered was considered as toxic dose. However, if the 
mortality was observed in only one animal out of three animals then the same dose 
was repeated again to confirm the toxic effect. If no mortality was observed, then 
higher (50, 300, 1000 and 2000 mg/kg) doses of the Poonaga parpam were employed 
for further toxicity studies. The following general behaviour was also observed during 
the acute toxicity study (Ecobichon DJ, 1997). 
3.1. Doses: 
 The doses for the study were selected based on literature search and range 
finding study. Following the period of fasting, the animals were weighted and then 
drug was administered orally as single dose using a needle fitted onto a disposable 
syringe of approximate size at the following different doses. 
Table – 3. Doses 
GROUP DOSE 
Group –I Control 
Group – II 5mg/kg 
Group – III 50mg/kg 
Group – IV 300mg/kg 
Group – V 2000mg/kg 
 
 The test substance was administered as single dose. After single dose 
administration period, all animals were observed for 14 days. 
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General Behaviours 
S.No General Behaviour 
1 Sedation 
2 Hypnosis 
3 Convulsion 
4 Ptosis 
5 Analgesia 
6 Stupar Reaction 
7 Motor activity 
8 Muscle Relaxant 
9 CNS Stimulant 
10 CNS Depressant 
11 Pilo Erection 
12 Skin Colour 
13 Lacrimation 
14 Stool Consistancy 
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SUB-ACUTE TOXICITY STUDY 
1.Objective 
 The objective of this ‘Sub-acute toxicity study of POONAGA PARPAM on 
Wistar Albino Rats’ was to assess the toxicological profile of the test substance when 
treated as a single dose. Animals should be observed for 28 days of drug 
administration. This study provides information on the possible health hazards likely 
to arise from exposure over a relatively limited period of time. 
 
2. Test Guideline followed 
 OECD 407 Method – Sub-Acute Toxic Class Method (Repeated Dose 28-Day 
Oral Toxicity Study in Rodents) 
 
3. Test substance Detail 
 Name: POONAGA PARPAM 
 Wistar albino rats of either sex weighing 150-200g were used in the study. The 
animals were divided in to 3 groups of 6 animals each.  Group I served as control 
received Distilled water (1ml/kg). Group II & III received the Poonaga parpam at the 
dose of 50 and 100 mg/kg respectively.  
 
Table 4. Animal Groupings 
Groups Drug Treatment 
I Control (1ml/kg, p.o) 
II Poonaga parpam (50mg/kg, p.o) 
III Poonaga parpam  (100mg/kg, p.o) 
  
Numbering and Identification 
 The animals were marked on body with picric acid solution prepared in water. 
The marking within the cage was as below. 
Table-5 Group Numbering and Identification animals were marking on body 
Group No Animal marking 
Control H,B,T, HB,BT,HT 
Low dose H,B,T,HB,BT,HT 
High dose H,B,T,HB,BT,HT 
H-head, B-body, T-tail 
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 The group no., cage no., sex of the animal and animal no. were identified as 
indicated below using cage . label and body marking on the animals: 
 
Table-6. Numbering and Identification cage label and body marking                        
on the animals. 
Cage no Group no Animal marking Sex 
1 Control 
H,B,T Male 
HB,BT,HT Female 
2 Low dose 
H,B,T Male 
HB,BT,HT Female 
3 High dose 
H,B,T Male 
HB,BT,HT Female 
HB – Head Body, BT – Body Tail, HT – Head Tail 
 The vehicle (Honey) and test drugs were administered orally, once daily for 28 
days. Body weight, food intake and water intake were monitored at regular intervals. 
The animals were sacrificed on 29th day for biochemical and histopathological 
studies. Prior to the sacrifice, animals were isolated in individual cages and fasted for 
12 hr, with water provided ad libitum.  
 Then, they were anaesthetized with pentobarbitone (45mg/kg, i.p) and the 
blood was collected by sino-orbital puncture. Blood samples for the determinations of 
hematological parameters (Ghai, 1995) were collected in heparinized tubes and used 
for the following determinations, hemoglobin (Hb), red blood cell (RBC) count, white 
blood cell (WBC) count and differential count (DC)  
 Non-heparinized tubes were used for serum biochemistry determinations. To 
obtain the serum, blood samples were placed at room temperature for approximately 
30 min. Then, the tubes were centrifuged at 3000 x g for 10 min and the supernatants 
were taken for the determinations of SGPT (AST), ALT (SGOT), ALP, Creatinine, 
Blood urea nitrogen, Creatinine Phosphokinase and Lactate Dehydrogenase.  
Estimation of AST and ALT 
  Activities of serum Aspartate transaminase (AST) and Alanine transaminase 
(ALT) were assayed by the method of Reitman and Frankel, 1957. 0.2 ml of serum 
with 1 ml of substrate (aspartate and α-ketoglutarate for AST; alanine and α -keto 
glutarate for ALT, in phosphate buffer pH 7.4) was incubated for an hour in case of 
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AST and 30 minutes for ALT. 1 ml of DNPH solution was added to arrest the reaction 
and kept for 20 min in room temperature. After incubation 1 ml of 0.4N NaOH was 
added and absorbance was read at 540 nm. Activities expressed as IU/L. 
Estimation of ALP (King, 1965)  
 Set up three test-tubes. Into the 1st (test), added 5 ml of the substrate solution 
(p-nitrophenyl phosphate in glycine/NaOH buffer) followed by 0.1 ml of serum. After 
30 minutes reaction at 370C, the optical density was measured at 405 nm. Into the 2nd 
tube, 5 ml of substrate solution was added with 0.1 ml of serum. After mixing, the 
optical density was measured immediately. Into the 3rd tube, 0.1 ml of water was 
added with 5.0 ml of p – nitrophenol standard solution, optical density was measured.     
Estimation of Blood Urea (Natelson et al., 1951)  
 Labeled three test-tubes as B, T and S. Into B, pipette, 0.02 ml water, into T, 
0.02 ml blood and into S, 0.02 ml standard urea solution (40 mg urea in 100 ml of 
water). 0.1 ml of diacetyl monoxime solution and 5 ml of acid regent 
(Thiosemicarbazide) was added into all the test-tubes. Mixed and kept in a boiling 
water bath for 15 minutes. After cooling, the absorbance was read at 540 nm and 
concentration of urea in mg/dl was calculated.    
 Estimation of Serum Creatinine (Slot, 1965) 
 Labeled three test-tubes as B, T and S. Into B, pipetted, 2 ml of water, into T, 
2 ml serum and 4 ml of water, into S, 3 ml of water and 1 ml of creatinine standard 
(4mg/dl). 2 ml of ammonium sulphate and 2 ml of sodium tungstate was added in all 
the three test-tubes. Centrifuged and removed 3 ml of supernatant from each test tube. 
1 ml of picric acid and distilled water was added to the supernatant of test tubes B, T 
and S. Absorbance was read at 520 nm and concentration of serum creatinine in mg/dl 
was calculated. 
Determination of Creatine Phosphokinase  
 The activity of CK was estimated by the method of Rosalki (1967).  CK 
catalyses the conversion of creatine phosphate and ADP to creatine and ATP. The 
ATP and glucose are converted to ADP and glucose-6-phosphate by hexokinase 
(HK). Glucose -6-phosphate dehydrogense (G-6-PDH) oxidizes D-glucose-6-
phosphate and reduces the nicotinamide adenine dinucleotide (NAD). The rate of 
NADH formation, measured at 340nm, is directly proportional to serum CK activity. 
One ml of working reagent was added to 50 µl of test sample, mixed and incubated at 
37o C for 1min. After incubation, change in the optical density was measured for 3 
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min at an interval of 1min against blank at 340nm. The activity of creatine 
Phosphokinase was expressed as U/L. 
Determination of Lactate Dehydrogenase 
 The activity of LDH was estimated by the method of Teitz,1976. The enzyme 
LDH is distributed in tissues particularly in heart, muscle and kidney. LDH catalyzes 
the oxidation of lactate to pyruvte in the presence of NAD which is subsequently 
reduced to NADH. The rate of NADH formation was measured at 340nm and is 
directly proportional to LDH activity. One ml of the working reagent was added to 10 
µl of test sample, mixed and incubated at 37o C for 1min. After incubation, change in 
the optical density was measured for 1min at an interval of 1 min against reagent 
blank at 340 nm. The activity of LDH was expressed as U/L. 
 After blood collection, the animals were sacrificed by cervical decapitation 
and the organs such as brain, heart, liver, spleen, kidney and testis were removed and 
weighed. The organs were preserved in 10% buffered formaldehyde for 
histopathological observations. 
 
HISTOPATHOLOGICAL STUDIES 
 Anatomy of the liver was studied immediately after sacrificing the animals. A 
small portion was fixed in 10% neutral buffered formalin as described by Luna 14. 
Thin sections of 4-5µm were taken, stained with Haematoxylin and Eosin and 
histology was studied. 
Statistical Analysis 
 The values were expressed as mean ± SEM. The statistical analysis was 
carried out by one way analysis of variance (ANOVA) followed by Dunnett’s‘t’ – test 
using graph pad version I. P values <0.05 were considered significantly. 
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7. RESULT AND INFERENCES 
QUALITATIVE AND QUANTITATIVE ANALYSIS 
 
Table -7 
Colour characters of POONAGA PARPAM 
S.No Nature of drug Nature of colour 
1 POONAGA PARPAM Sensaayal 
 
 
Table 8— Physicochemical analysis of samples of POONAGA PARPAM 
[Values are mean of three determinations ±SEM] 
Parameters Total ash Values 
Ash value 
Water soluble ash 
Acid insoluble ash 
8.65±0.011 
0.75±0.011 
Loss on drying Loss on drying at 70°C 7.20±0.240 
SEM- singularity expansion method 
 
 
Table-9 
Particle size and pH of POONAGA PARPAM 
S.No Parameters Values obtained 
1 Particle size by SEM 0.5-2 µ 
2 pH 8.840 
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PHYTOCHEMICAL ANALYSIS 
PHYTO-CHEMICAL STUDY OF POONAGA PARPAM 
 
  This experimental study was taken up to qualitative analysis of Phyto-
chemicals in the drug of Poonaga Parpam using various test and the results are 
exhibited in Table No.10 
 
Table No 10: Incidence of various phyto-chemicals in Poonaga Parpam 
 
S.No. Name of Tests Conducted Result Observed 
Observation of Alkaloids 
1. Mayer’s Test Negative 
2. Dragendroff’s Test Negative 
3. Hager’s Test  Negative 
Observation of Carbohydrates and Glycosides 
4. Molisch Test  Positive 
5. Legal’s Test Positive 
6. Borntrager’s Test for anthraquinones Positive 
Observation of Phytosterols 
7. Liebermann – Burchard Test Negative 
8. Salkowski Test Negative 
Observation of Flavanoids 
9. 
Shinoda Test 
(Magnesium turnings & Hydrochloric acid) 
Negative 
10. Fluorescence Test Negative 
Observation of Tannins 
11. Ferric chloride test Negative 
12. Potassium dichromate test Negative 
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13. Lead acetate test Positive 
14. Millon’s test Negative 
15. Biuret test Positive 
16. Ninhydrin test Negative 
Observation of fixed oils and fats 
17. Spot test Negative 
18. Saponification test Negative 
Observation of Lignin 
19. Phloroglucinol test Negative 
Observation of Saponins 
20. Frothing test Negative 
 
Note: Positive indicates the presence of Phytochemical; Negative indicates the 
absence of Phytochemical 
 
Result :   
  Phytochemical analysis of poonaga Parpam shows the presence of 
carbohydrates, glycosides and tannins. 
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FOURIER TRANSFORM - INFRARED SPECTROSCOPY 
IR TRACER - 100 THE NEW FOURIER TRANSFORM INFRARED 
SPECTROPHOTOMETER 
Chart- 1 FTIR results of Poonaga Parpam 
 
Table – 11 Functional group by FTIR study 
FREQUENCY cm-1 BOND FUNCTIONAL GROUP 
424.34(M) C-I stretch Halo Compounds 
572.86(M) C-I stretch Halo Compounds 
601.79(M) C-Br stretch Alkyl Halides 
777.31(M) C-CI stretch Alkyl Halides 
1043.49(M) C-N stretch Aliphatic amines 
1095.57(M) C-N stretch Aliphatic amines 
1510.26(S) N-O asymmetric stretch Nitro Compounds 
1546.91(S) N-O asymmetric stretch Nitro Compounds 
2308.79(S) O=C=O stretch Carbon dioxide 
2349.30(S) O=C=O stretch Carbon dioxide 
2879.72(M) C-H stretch Alkane 
S-strong, W-weak, M-medium 
Result: FTIR study of Poonaga Parpam  shows the presene of functional groups such 
as Halo compounds, Alkyle halides, Aliphatic amines, Nitro compounds, Carbon 
dioxide and Alkane. 
70 
 
SEM ANALYSIS 
Scanning Electron Microscope (SEM) 
 
SEM -7000 Magnification 
 
SEM -14000 Magnification 
Result: 
 The particles were stabilized and have irregular morphology. The particles 
were distributed in range 100µm and the size is below 4 µm 
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ICP – OES of POONAGA PARPAM 
ICP – OES of PP 
S. No Elements Wavelength (nm) Concentration 
1. Al 396.152 BDL 
2. As 188.979 BDL 
3. Ca 315.807 02.080mg/L 
4. Cd 228.802 BDL 
5. Cu 327.393 82.561mg/L 
6. Fe 238.204 01.306mg/L 
7. Hg 253.652 BDL 
8. K 766.491 03.021mg/L 
9. Mg 285.213 01.204mg/L 
10. Na 589.592 01.300mg/L 
11. Ni 231.604 BDL 
12. Pb 220.353 BDL 
13. P 213.617 196.381mg/L 
 
BDL: Below Detectable Limit(Normal-1ppm) 
       1%  = 10000ppm, 
  1ppm = 1/1000000 or 0.0001% 
Results: 
  The result indicate that the formulation is extremely safe as it contains heavy 
metals within specified limits.  
  It also has physiologically important minerals like Calcium, Copper, 
Ferrous,Magnesium, Sodium, Phosphorus and Potassium. In Poonaga Parpam , the 
heavy metals like Arsenic, Mercury, Lead, Cadmium and trace element like Nikkal 
were below detectable level. This reveals the safety of the drug and it has free from 
toxic substances and has no side effects.  
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XRD of POONAGA PARPAM 
 
 
Result: 
        These XRD fingerprints shows both the similarities and differences of the 
sample  successfully and is a valuable primary tool for checking the quality control of 
herbo animal  medicines. Modern techniques are necessary to standardize and 
bringout high quality herbal  products owing their complex nature. The different 
peaks shows the presence of minerals in the  sample. 
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BIO-CHEMICAL ANALYSIS OF POONAGA PARPAM 
 
Preparation of the extract:   
  100mgs of parpam is weighted accurately and placed into a clean beaker and 
added a few drops of Conc.  Hydrochloric acid and evaporated it well. After 
evaporation cooled the content and added a few drops of conc. nitric acid and 
evaporated it well. After cooling the content  add 20ml of distilled water and 
dissolved it well. Then it is transferred to 100ml volumetric flask and made up to 
100ml with distilled water, mix well, filter it. Then it is taken for analysis. 
Table No. 12 
S.NO EXPERIMENTS OBSERVATION INFERENCE 
1. Test for calcium: 
2 ml 0f the above prepared extract 
taken in a clean test tube to this add 
2 ml of 4% ammonium oxalate 
solution. 
Formation of white 
colour  precipitate 
 
presence of 
calcium 
 
2. Test for sulphate: 
2 ml of the extract is added to 5% 
barrium chloride solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
sulphate. 
3. Test for chloride: 
The extract is treated with silver 
nitrate solution. 
 
Formation of white 
colour  precipitate 
 
Presence of 
chloride. 
 
4. Test for carbonate: 
The substance is treated with 
concentrated HCL. 
 
No brisk 
effervescence is 
formed. 
 
Absence of 
carbonate. 
5. Test for starch: 
The extract is added with weak 
iodine solution. 
 
No blue colour is 
formed 
 
Absence of 
starch. 
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6. Test for ferric iron: 
The extract is acidified with glacial 
acetic acid and potassium ferro 
cyanide. 
 
No blue colour is 
formed 
 
Absence of ferric 
iron. 
7. Test for ferrous iron: 
The extract is treated with 
concentrated nitric acid ammonium 
thiocyanide solution. 
 
Appearance of 
blood red colour. 
 
presence of 
ferrous iron 
8. Test for phosphate: 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
 
Formation of yellow 
precipitate 
 
 
presence of 
phosphate. 
 
9. Test for albumin: 
The extract is treated with esbach’s 
reagent. 
 
No yellow 
precipitate is formed 
Absence of 
albumin. 
10. Test for tannic acid: 
The extract is treated with ferric 
chloride. 
No blue black 
precipitate is formed 
Absence of 
tannic acid. 
 
11. Test for unsaturation: 
Potassium permanganate solution 
is added to the extract. 
 
It does not get 
decolourised. 
 
Absence of 
unsaturated 
compounds. 
12. Test for the reducing sugar: 
5ml of benedict’s qualitative 
solution is taken in a test tube and 
allowed to boil for 2 minutes and 
add 8 to 10 drops of the extract and 
again boil it for 2 minutes. 
No Colour change 
occurs. 
 
Absence of 
reducing sugar. 
13. Test for amino acid: 
One or two drops of the extract is 
placed on a filter paper and dried 
well. After drying, 1 %  ninhydrin 
is sprayed over the same and dried 
it well. 
No Violet colour is 
formed 
 
Absence of 
amino acid. 
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14. Test for zinc: 
The extract is treated with 
potassium  ferro cyanide. 
No white precipitate 
is formed 
Absence of zinc. 
 
Inference: 
 The Biochemial analysis of POONAGA PARPAM indicates the presence of 
calcium, sulphate, chloride, ferrous iron and phosphate. 
  Biochemical Analyis report was given by Mrs. N.Nagaprema, M.Sc., H.O.D, 
Bio Chemical Department, Government Siddha Medical College, Palayamkottai. 
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ACUTE TOXICITY STUDY ON POONAGA PARPAM 
 
Effect of Acute Toxicity (14 Days) of Poonaga Parpam 
Table 13 Physical and behavioral examinations. 
Group no. Dose(mg/kg) Observation sign Mortality. 
Group-I Control Normal 0 of 3 
Group- II 5 mg/kg Normal 0 of 3 
Group-III 50 mg/kg Normal 0 of 3 
Group-IV 300 mg/kg Normal 0 of 3 
Group-V 2000 mg/kg Normal 0 of 3 
 
Table – 14  shows the effect of control – distilled water ( 1ml/kg ) on general 
behavior after single oral administration in Rat. 
Sl .No General Behavior 
Time of observation after control – distilled 
water ( 1ml/kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table - 15 shows the effect of Poonaga Parpam ( 5mg/kg ) on general behavior 
after single oral administration in Rat. 
Sl.No General behaviour 
Time of observation after Poonaga Parpam 
( 5 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-16  shows the effect of Poonaga Parpam ( 50mg/kg ) on general behavior 
after single oral administration in Rat. 
 
Sl.No General behaviour 
Time of observation after Poonaga Parpam 
( 50 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-17  shows the effect of Poonaga Parpam ( 300mg/kg ) on general behavior 
after single oral administration in Rat. 
 
Sl.No General behaviour 
Time of observation after Poonaga Parpam 
( 300 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-18  shows the effect of Poonaga Parpam (2000 mg/kg ) on general behavior 
after single oral administration in Rat. 
 
Sl.No General behaviour 
Time of observation after Poonaga Parpam 
(2000 mg / kg ) administration 
1st hour 3rd hour 4th hour 24th hour 
1 Sedation - - - - 
2 Hypnosis - - - - 
3 Convulsion - - - - 
4 Ptosis - - - - 
5 Analgesia - - - - 
6 Stupor reaction - - - - 
7 Motor activity - - - - 
8 Musle relaxant - - - - 
9 CNS stimulant - - - - 
10 CNS depressant - - - - 
11 Pilo erection - - - - 
12 Skin colour changes - - - - 
13 Lacrimation - - - - 
14 Stool consisteny - - - - 
+ Present, - Absent 
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Table-19  Home cage activity 
Functional and 
Behavioral 
observation 
O
bs
er
v
a
tio
n
 5mg/kg 
Group 
(G-I) 
50mg/kg 
(G-II) 
300mg/kg 
(G-III) 
1000mg/kg 
(G-IV) 
2000mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Body position Normal 3 3 3 3 3 
Respiration Normal 3 3 3 3 3 
Clonic involuntary 
Movement 
Normal 
behaviour 3 3 3 3 3 
Tonic involuntary 
Movement 
Normal 
behaviour 3 3 3 3 3 
Palpebral closure Normal 3 3 3 3 3 
Approach 
response Normal 3 3 3 3 3 
Touch response Normal 3 3 3 3 3 
Pinna reflex Normal 3 3 3 3 3 
Tail pinch 
response Normal 3 3 3 3 3 
 
Table-20  Hand held observation 
Functional and 
Behavioral 
Observation 
O
bs
er
v
a
tio
n
 
Control 
5  
mg/ kg 
(G-I) 
50 
mg/kg 
(G-II) 
300 
mg/kg 
(G-III) 
1000 
mg/kg 
(G-IV) 
2000 
mg/kg 
(G-V) 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Female 
n=3 
Reactivity Normal 3 3 3 3 3 3 
Handling Normal 3 3 3 3 3 3 
Palpebral closure Normal behaviour 3 3 3 3 3 3 
Lacrimation Normal behaviour 3 3 3 3 3 3 
Salivation Normal behaviour 3 3 3 3 3 3 
Piloerection Normal behaviour 3 3 3 3 3 3 
Pupillary reflex Normal 3 3 3 3 3 3 
Abdominal tone Normal 3 3 3 3 3 3 
Limb tone Normal 3 3 3 3 3 3 
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Table-21  Mortality 
Group No Dose No (mg/kg) Mortality 
Group-I Control 0 of 3 
Group-II 5 (mg/kg) 0 of 3 
Group-III 50 (mg/kg) 0 of 3 
Group-IV 300 (mg/kg) 0 of 3 
Group-V 2000(mg/kg) 0 of 3 
 
  The results of acute toxicity study of Poonaga parpam was shown on table 15. 
The Poonaga parpam did not alter the general behavior after 1hour to 24hours of oral 
administration. There was no mortality with the Poonaga parpam after 1hr to 24 hrs 
even at higher dose of 2000mg/kg. It did not show any lethality or toxic reactions 
during and after the study. From the doses administered in acute toxicity study, their 2 
doses  50 and 100 mg/kg were selected for sub-acute toxicity study.  
 
 
  
 Table 22. Effect of Poonaga parpam on body weight during 28 days 
Groups 
Drug 
Treatment 
I 
Control – 
Distilled water 
(1ml/kg, p.o) 
II 
Poonaga 
parpam 
(50mg/kg, p.o) 
III 
Poonaga 
parpam 
(100mg/kg, p.o) 
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 1. Effect of Poonaga parpam on body weight during 28 days drug 
83 
SUB-ACUTE TOXICITY STUDY 
administration in rats 
Body Weight (gms)
1st Day 7th Day 14th Day 
168.73± 
3.42 
176.22± 
4.97 
196.34± 
4.77 
193.33± 
16.46 
203.33± 
17.20 
201.66± 
24.98 
215± 
17.41 
219.16± 
21.63 
210.83± 
25.14 
 
 
administration in rats 
drug 
 
21st Day 28th Day 
210.54± 
6.04 
220.22± 
4.40 
203.33± 
20.72 
195.83± 
21.5 
210± 
23.38 
209.16± 
21.73 
 
  
Table 23. Effect of Poonaga parpam on food intake during 28 days 
Groups 
Drug 
Treatment 
I 
Control - 
Distilled water 
(1ml/kg, p.o) 
II 
Poonaga 
parpam 
(50mg/kg, p.o)
III 
Poonaga 
parpam 
(100mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 2. Effect of Poonaga parpam on food intake during 28 days drug
84 
administration in rats 
Food Intake (gms)
1st Day 7th Day 14th Day 
38.42±1.32 42.56±2.86 39.30±2.20 53.75±3.19
 
60.42±3.77 68.54±2.90 65.00±3.72 45.64±2.20
 
65.74±2.60 69.87±3.33 69.50±3.05 70.60±3.75
 
 
administration in rats 
drug 
 
21st Day 28th Day 
 56.90±2.72 
 50.80±3.66 
 75.88±3.26 
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Table 24. Effect of Poonaga parpam on water intake during 28 days drug 
administration in rats 
Groups Drug Treatment 
Water Intake (ml) 
1st Day 7th Day 14th Day 21st Day 28th Day 
I 
Control - Distilled 
water 
(1ml/kg, p.o) 
51.66± 
2.02 
58.76± 
4.22 
64.00± 
3.90 
70.34± 
4.73 
65.76± 
4.80 
II 
Poonaga parpam 
(50mg/kg, p.o) 
63.20± 
3.20 
72.53± 
3.25 
67.35± 
2.52 
77.72± 
3.24 
75.80± 
3.27 
III 
Poonaga parpam 
(100mg/kg, p.o) 
85.49± 
4.75 
67.35± 
3.60 
67.35± 
4.77 
72.53± 
4.54 
77.72± 
6.24 
Values are in mean ± SEM (n=6) 
*P<0.05, **P<0.01, ***P<0.001 Vs Control 
 
Figure 3. Effect of Poonaga parpam on water intake during 28 days drug 
administration in rats 
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 Table 25. Shows the effect of Poonaga parpam on RBC, WBC and Hb in rats 
Groups Drug Treatment
I 
Control 
water
(1ml/kg, p.o)
II 
Poonaga parpam 
(50mg/kg, p.o)
III 
Poonaga parpam 
(100mg/kg, p.o)
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 4. Shows the effect of Poonaga parpam on RBC and Hb in rats after 28 
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after 28 days drug administration 
 
RBC million 
cells/cmm 
WBC 
cells/cmm 
– Distilled 
 
 
4.57 ± 
0.16 
8638.52± 
87.66 
 
4.53 ± 
0.23 
8355.83± 
136.48 
 
4.77 ± 
0.18 
9317.47± 
132.20 
 
 
days drug administration 
Haemoglobin 
gm  % 
11.77± 
0.28 
11.80± 
0.30 
11.56± 
0.47 
 
  
Figure 5. Shows the effect of Poonaga parpam on WBC in rats after 28 days drug 
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administration 
 
 
 
 Shows the effect of Poonaga parpam on Differential Count in rats after 28 days 
 
Groups 
Drug Treatment
I 
Control -
water
(1ml/kg, p.o)
II 
Poonaga parpam 
(50mg/kg, p.o)
III 
Poonaga parpam 
(100mg/kg, p.o)
 
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 6. Shows the effect of Poonaga parpam on Differential Counts in rats 
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drug administration 
 
Differential Count %
Neutophils Eosinophils Monocyte
 Distilled 
 
 
30.00± 
1.79 
1.17± 
0.31 
3.33±
0.42
 
28.20± 
0.49 
1.20± 
0.20 
2.80±
0.37
 
29.60± 
1.44 
1.60± 
0.24 
3.60±
0.40
 
 
after 28 days drug administration 
 
 
 Lympocyte 
 
 
65.83± 
1.64 
 
 
68.80± 
2.42 
 
 
66.60± 
1.17 
 
 Table 26. Shows the effect of Poonaga parpam on Hepatic Functions (SGPT, 
SGOT and ALP) in rats after 28 days 
 
Groups Drug Treatment
I 
Control -
water
(1ml/kg, p.o)
II 
Poonaga parpam 
(50mg/kg, p.o)
III 
Poonaga parpam 
(100mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 7. Shows the effect of 
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drug administration
 
 
SGPT 
(IU/L) 
SGOT 
(IU/L) 
 Distilled 
 
 
83.83± 
1.42 
150.17± 
4.59 
 
88.20± 
2.71 
152.00± 
3.83 
 
110.40± 
3.89 
177.60± 
3.88 
 
 
Poonaga parpam on Hepatic Functions  in rats after 
28 days drug administration 
 
 
ALP 
(IU/L) 
270.83± 
4.17 
273.80± 
3.53 
290.20± 
3.39 
 
 Table Shows the effect of Poonaga parpam on Kidney Functions in rats after 28 
Groups Drug Treatment
I 
Control 
(1ml/kg, p.o)
II 
Poonaga parpam 
(50mg/kg, p.o)
III 
Poonaga parpam 
(100mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 8. Shows the effect of Poonaga parpam on Kidney Functions (Blood Urea 
and Creatinine)  in rats after 28 days drug administration
 
 
 
 
 
90 
daysdrug administration 
 
Urea 
(mg/dl) 
- Distilled water 
 
34.67± 
1.12 
 
37.00± 
3.21 
 
61.80± 
1.88 
 
 
Creatinine 
(mg/dl) 
0.84± 
0.07 
1.07± 
0.15 
1.63± 
0.29 
 
 
 Table Shows the effect of Poonaga parpam on Cardiac Functions in rats after 28 
 
Groups 
Drug 
I 
Control 
(1ml/kg, p.o)
II 
Poonaga parpam 
(50mg/kg, p.o)
III 
Poonaga parpam 
(100mg/kg, p.o)
Values are in mean ± SEM (n=6)
*P<0.05, **P<0.01, ***P<0.001 Vs Control
 
Figure 9. Shows the effect of Poonaga parpam on Cardiac Functions (Creatinie 
Phosphokinase and Lactate Dehydrogenase and in rats after 28 days drug 
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days drug administration 
Treatment 
Creatinine 
Phosphokinase 
(IU/L) 
- Distilled water 
 
146.83± 
4.79 
 
162.20± 
4.75 
 
203.20± 
4.38 
 
 
administration 
Lactate 
Dehydrogenase 
(IU/L) 
543.50± 
7.72 
597.80± 
8.21 
734.40± 
7.89 
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HISTOPATHOLOGICAL STUDIES 
 
HEART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULT :   
   Normal cardiac muscle fibers seen 
  
CONTROL LOW DOSE (50mg/kg) 
HIGH DOSE (100mg/kg) 
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LIVER 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULT :   
  Normal  Liver parenchyma seen 
  
CONTROL LOW DOSE (50mg/kg) 
HIGH DOSE (100mg/kg) 
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KIDNEY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULT :   
  Normal  Renal parenchyma seen 
 
RESULT 
  In sub-acute toxicity study, body weight, food intake and water intake were 
observed on 1st, 7th, 14th 21st and 28th day of Poonaga parpam after drug 
administration. The effect of Poonaga parpam regarding body weight during 28 days 
treatment in rats was given in table 19 and as figure 1. There was no significant 
change in the body weight compared to control with all the two doses of Poonaga 
parpam during 28 days treatment. 
CONTROL LOW DOSE (50mg/kg) 
HIGH DOSE (100mg/kg) 
95 
 
  The effect of Poonaga parpam on food intake during 28 days treatment in rats 
was given in table 19 and figure 2. Poonaga parpam did not alter the food intake at 
both the dose levels as compared to control during the 28 days treatment. It indicates 
that it does not influence food intake.  
  The effect of Poonaga parpam on water intake during 28 days treatment in rats 
was given in table 21 and figure 3. Poonaga parpam did not alter the water intake at 
both the dose levels as compared to control during the 28 days treatment. 
   Table 22, figure 4 and 5, shows the effect of Poonaga parpam on 
haematological parameters like RBC, WBC and Hb in rats after 28 days treatment. 
Both the doses of Poonaga parpam did not produce any significant change in RBC 
and Hb compared to control. Poonaga parpam at high dose (100mg/kg) significantly 
(P<0.05) increase the WBC count as compare to control but low dose (50mg/kg) did 
not show any significant change in WBC count. 
  The effect of Poonaga parpam on Differential Count in rats after 28 days 
treatment was shown on table 23 and figure 6. Both the doses of Poonaga parpam did 
not show any significant change in differential counts like Neutrophils, Eosinpophils, 
Monocyte and Lympocytes. From the effect of Poonaga parpam on hematological 
parameters it was found that it does not produce any toxicity in haemopoietic system 
except mild increase in WBC at high dose. 
  The blood samples are used to evaluate Hematological parameters (like RBC, 
WBC, HB and DC) and evaluate biochemical parameters (like SGOT, SGPT, ALP, 
UREA and CREATININE). The changes in haematological parameters and 
biochemical parameters are within normal limits. 
  On completion of the 28days administration of poonaga parpam, Wistar 
Albino Rats were sacrificed. In macroscopic examination the Heart, Kidneys and 
Liver organs were weighed. The organs were normal when compared with control 
group. Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
 
  In sub-acute toxicity study shows that Poonaga Parpam can be considered 
safe, as it did not cause either any lethality or adverse changes with general behaviour 
of  rats and also there were no observable detrimental effects on 50mg/kg and 
100mg/kg over a period of 28 days.  It is concluded that the Poonaga Parpam is 
relatively safe when administered orally in human for long administration upto the 
dose  100mg/kg. 
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BIOSTATISTICAL ASPECTS 
  Biological assay refers to assessment of the potency of vitamins, hormones, 
toxicants and drugs of all types by means of the responses produced when doses are 
given to experimental animals. In every dose response situation, two components 
must be considered; the stimulus and the subject. 
  The stimulus is applied to the subject as a started dose namely concentration, 
weight, time or appropriate measure. The subject manifest a response, the level of 
intensity below which the response does not occur & above which the response occur, 
suh a value has often been called threshold. But the term tolerance is now widely 
accepted. 
 
MEDIAN EFFECTIVE DOSE (E.D.50) 
 It is the dose which produces the desired response in half the animal 
population tested. 
 
MEDIAN EFFECTIVE DOSE (E.D.50) 
 It is the dose which kills half the population of the animal tested. 
 
LD50 Measurement (Toxicity) 
 If the test compound shows any pharmacological activity then the L.D.50 of 
the drug is determined. 
 By determining the L.D.50, we can justify whether to proceed with the drug or 
not. 
Table- 27  Acute toxicity study analysis 
Group Dose in mg/kg No. of rats No. of rats died 
I Distilled water 
(1ml/kg) 
3 - 
II 5 3 - 
III 50 3 - 
IV 300 3 - 
V 2000 3 - 
 
  Since there was no mortality of the animal in acute toxicity study, lethal dose 
of drug could not be calculated. 
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Table – 28: Sub – Acute Toxicity Analysis 
Group Dose (mg/kg) No.of rats Days No.of rats died 
I Control 
6 (3 male,           
3 female) 
28 - 
II 50 
6 (3 male,           
3 female) 
28 - 
III 100 
6 (3 male,           
3 female) 
28 - 
 
 In case of Sub – Acute Toxicity Study, with the help of physiological 
parameters such as Haematological investigations and with the Histopathological 
studies the drug reaction within the animal can be assessed and are being tabulated 
respectively. 
 Lethal dose of the drug “Poonaga Parpam”can be calculated with higher 
dose level of the drug which can be done in further studies. 
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8. DISCUSSION 
  The preclinical toxicity study of poonaga Parpam was conducted with the 
prime objective to find out whether the drug has possess any side effects or adverse 
reactions on long term administration. 
  Biochemical analysis of Poonaga Parpam indicated the presence of calcium, 
sulphate, chloride, ferrous iron and phosphate. Heavy toxic metals such as lead, 
mercury, arsenic, and zinc were absent. 
  Phytochemical analysis of poonaga Parpam shows the presence of 
carbohydrates, glycosides and tannins. 
  FTIR study of Poonaga Parpam shows the presene of functional groups such 
as Halo compounds, alkyl halides, aliphatic amines, nitro compounds, carbon dioxide 
and alkanes 
  Scanned Electron Microscope study of end product shows that the particles 
were stabilized and have irregular morphology. The particles were distributed in range 
100 µm and the size is below 4 µm 
  In acute toxicity study all the animals were active and did not showed any 
signs of toxicity. The motor activities were normal in all the 6 groups of animals.  
This acute toxicity study results reveals that poonaga Parpam was nontoxic upto a 
dose level of 2000mg/kg body weight of the animal. 
  Doses for sub-acute toxicity study were selected on the basis of acute toxicity 
study. The selected doses were 50mg/kg and 100mg/kg  body weight of the animal. 
In sub-acute toxicity study no signs of toxicity were observed. No changes in the 
hematological parameters. There was no changes in food intake, water intake and 
body weight. No mortality occurred till the last day of the study.  
  Necropsy study of the major organs liver, kidney and heart showed no 
apparent change in colour. The texture of the organs maintained and the specimens 
were normal on  macroscopical examination when compared with that of the control 
group.  
  Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
  Since, there was no mortality in both acute and sub-acute toxicity studies the 
lethal dose of the drug could not be calculated. The biostatistical analysis reveals that 
poonaga Parpam is safe up to a dose level of 2000mg /kg body weight of the animal.  
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9. SUMMARY 
  The ingredients of Poonaga Parpam were purified and the drug was prepared 
according to the process mentioned in Anuboga vaidhya navaneetham (Part – 3, 
Pg.No. 117, Second Edition - 2002, Hakim P. Mohamed Abdulla Sahib), and it was 
selected for evaluating the toxic effects and mortality when given in short and long 
duration. The aim of this study is to evaluate the safety of the drug Poonaga Parpam 
by administering it to Wistar albino rats at various dose levels.  
  In review of literature, the ingredients of poonaga Parpam were discussed in 
depth with a special attention paid to their medicinal uses and toxicological aspects.  
  The ingredients of Poonaga Parpam are poonagam and madhulai.  The 
poonagam were purchased from Sankarankovil and madhulai collected from 
Tirunelveli.  
  The raw samples were taken purification and test medicine was prepared, 
asper the method narrated in the literature. 
  Biochemical analysis of Poonaga Parpam indicated the presence of calcium, 
sulphate, chloride, ferrous iron and phosphate. Heavy toxic metals such as lead, 
mercury, arsenic, and zinc were absent. 
  Phytochemical analysis of poonaga Parpam shows the presence of 
carbohydrates, glycosides and tannins. 
  FTIR study of Poonaga Parpam  shows the presene of functional groups such 
as Halo compounds, alkyl halides, aliphatic amines, nitro compounds, carbon dioxide 
and alkanes 
  Scanned Electron Microscope study of end product shows that the particles 
were stabilized and have irregular morphology. The particles were distributed in range 
4µ and the size is below 100 µm 
  The Acute toxicity study was conducted to know single dose toxicity of 
POONAGA PARPAM on female Wistar Albino Rats. The study was conducted using 
15 female Wistar Albino Rats. The female animals were selected for study of 6 weeks 
old with weight range of within ±20% of mean body weight at the time of 
randomization. The groups were numbered as group I, II, III, IV and V and dose with 
control, 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg of POONAGA PARPAM. The 
drug was administered by oral route as single dose and observed for 14 days. Daily 
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the animals were observed for clinical signs and mortality. Body weight of animals 
was recorded once in a week. 
  There were no physical and general behavioral changes observed in wistar 
albino rats of 5mg/kg, 50mg/kg, 300mg/kg and 2000mg/kg to rats during 14 days. 
Body weight of all animals did not reveal any significant change as compared to  
control group.  
  Food consumption of all group animals was normal 
  Mortality was not observed in all treated groups.  
 In Sub-acute toxicity study the animals were selected randomly grouped into 3 
different groups containing minimum 6 animals (3 male, 3 female in each group) . 
The groups were numbered as group I, II,  and dose with control, 50mg/kg (low dose), 
100mg/kg (High dose), of POONAGA PARPAM. The POONAGA PARPAM was 
administered as single dose for 28 days and all animals were observed daily once.  
These observations were also performed on week ends.  
  The observations included clinical signs of toxicity, food intake, water intake, 
body weight. No signs of toxicity were observed. There was no significant changes in 
food intake, water intake and body weight. No mortality occurred till the last day of 
the study. 
  The blood samples were used to evaluate Hematological parameters (like 
RBC, WBC, HB,DC) and evaluate biochemical parameters (like SGOT, SGPT, ALP, 
UREA and CREATININE). No changes in haematological parameters and 
biochemical parameters. 
  On completion of the 28th day of drug administration, Wistar Albino Rats were 
sacrificed. In macroscopic examination the Heart, Kidneys and Liver organs were 
weighed. The organs were normal when compared with control group. 
Histopathological examination revealed normal architecture in comparison with 
control and drug treated animal. 
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10. CONCLUSION 
 
 Poonaga parpam was studied for its acute and sub-acue toxicity effect using 
laboratory animals. In acute toxicity study, Poonaga parpam did not produce any 
specific toxicity or mortality even at the dose of 2000mg/kg in wister albino rats.So 
No - Observed – Adverse – Effect – Level (NOAEL) of Poonaga parpam is 
2000mg/kg body weight of animal.  In sub-acute toxicity study, 50 and 100mg/kg of 
Poonaga parpam was used and it was administered once daily for 28 days through oral 
route. In conclusion Poonaga Parpam can be considered safe, as it did not cause either 
any lethality or adverse changes with general behavior of rats and also there were no 
observable detrimental effects (50mg/kg, 100mg/kg) over a period of 28 days. It is 
concluded that the Poonaga Parpam is relatively safe when administered orally in 
human for long administration upto the dose 100mg/kg.  
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